| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Testing | 93 | 2024 | 3533 | 8.530 |
Why?
|
| Autistic Disorder | 33 | 2024 | 1219 | 5.800 |
Why?
|
| Genetic Predisposition to Disease | 142 | 2024 | 17878 | 5.250 |
Why?
|
| Mutation, Missense | 45 | 2024 | 2570 | 5.220 |
Why?
|
| DNA Copy Number Variations | 38 | 2024 | 2020 | 4.680 |
Why?
|
| Heart Defects, Congenital | 54 | 2024 | 4671 | 4.560 |
Why?
|
| Genomics | 62 | 2024 | 5822 | 4.170 |
Why?
|
| Genetics, Medical | 15 | 2024 | 334 | 4.130 |
Why?
|
| Mutation | 162 | 2024 | 30015 | 4.110 |
Why?
|
| Hypertension, Pulmonary | 33 | 2024 | 1582 | 4.110 |
Why?
|
| Microcephaly | 19 | 2024 | 425 | 3.620 |
Why?
|
| Chromosome Disorders | 16 | 2024 | 497 | 3.590 |
Why?
|
| Developmental Disabilities | 34 | 2024 | 1509 | 3.520 |
Why?
|
| Muscle Hypotonia | 17 | 2023 | 161 | 3.360 |
Why?
|
| Phenotype | 113 | 2024 | 16572 | 3.330 |
Why?
|
| Chromosomes, Human, Pair 16 | 23 | 2024 | 343 | 3.110 |
Why?
|
| Protein Phosphatase 2 | 12 | 2024 | 231 | 3.100 |
Why?
|
| Chromosome Deletion | 28 | 2024 | 1386 | 2.850 |
Why?
|
| Incidental Findings | 16 | 2023 | 697 | 2.660 |
Why?
|
| Genetic Counseling | 22 | 2023 | 627 | 2.620 |
Why?
|
| Breast Neoplasms | 76 | 2024 | 20988 | 2.460 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 6 | 2022 | 57 | 2.430 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 16 | 2023 | 72 | 2.280 |
Why?
|
| Genetic Association Studies | 35 | 2024 | 2734 | 2.270 |
Why?
|
| Pedigree | 50 | 2023 | 4539 | 2.260 |
Why?
|
| Child | 216 | 2024 | 80089 | 2.180 |
Why?
|
| Heterozygote | 47 | 2023 | 2780 | 2.150 |
Why?
|
| Humans | 673 | 2024 | 760740 | 2.090 |
Why?
|
| Genetic Variation | 37 | 2024 | 6561 | 2.090 |
Why?
|
| Sequence Analysis, DNA | 37 | 2024 | 4739 | 2.080 |
Why?
|
| Child, Preschool | 142 | 2024 | 42193 | 1.970 |
Why?
|
| Abnormalities, Multiple | 14 | 2023 | 1422 | 1.880 |
Why?
|
| Genetic Privacy | 6 | 2019 | 59 | 1.820 |
Why?
|
| Genotype | 63 | 2024 | 12977 | 1.800 |
Why?
|
| DNA Mutational Analysis | 28 | 2021 | 4110 | 1.780 |
Why?
|
| Parkinsonian Disorders | 3 | 2021 | 285 | 1.760 |
Why?
|
| Channelopathies | 3 | 2022 | 30 | 1.660 |
Why?
|
| Female | 393 | 2024 | 392203 | 1.650 |
Why?
|
| Frameshift Mutation | 10 | 2024 | 392 | 1.620 |
Why?
|
| Genetic Research | 6 | 2024 | 171 | 1.590 |
Why?
|
| BRCA1 Protein | 27 | 2024 | 1149 | 1.560 |
Why?
|
| Adolescent | 165 | 2024 | 88247 | 1.550 |
Why?
|
| Nervous System Malformations | 8 | 2024 | 244 | 1.530 |
Why?
|
| Genes, BRCA2 | 19 | 2024 | 590 | 1.510 |
Why?
|
| Germ-Line Mutation | 21 | 2023 | 1852 | 1.510 |
Why?
|
| BRCA2 Protein | 23 | 2024 | 797 | 1.480 |
Why?
|
| Ataxia | 6 | 2022 | 306 | 1.470 |
Why?
|
| Congenital Abnormalities | 5 | 2021 | 709 | 1.460 |
Why?
|
| Jews | 15 | 2024 | 356 | 1.450 |
Why?
|
| Male | 309 | 2024 | 360402 | 1.440 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 2 | 2021 | 61 | 1.410 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 3 | 2019 | 380 | 1.390 |
Why?
|
| Adult | 221 | 2024 | 220995 | 1.380 |
Why?
|
| Penetrance | 9 | 2024 | 382 | 1.380 |
Why?
|
| Neonatal Screening | 6 | 2023 | 597 | 1.360 |
Why?
|
| Genes, BRCA1 | 18 | 2024 | 753 | 1.360 |
Why?
|
| Informed Consent | 10 | 2020 | 1007 | 1.360 |
Why?
|
| Epilepsy | 24 | 2024 | 3303 | 1.350 |
Why?
|
| Infant | 106 | 2024 | 36157 | 1.350 |
Why?
|
| Lysine | 5 | 2023 | 993 | 1.330 |
Why?
|
| Chromosome Duplication | 11 | 2024 | 75 | 1.310 |
Why?
|
| Research Personnel | 4 | 2015 | 588 | 1.300 |
Why?
|
| RNA-Binding Proteins | 8 | 2022 | 1890 | 1.250 |
Why?
|
| Language Development Disorders | 7 | 2024 | 193 | 1.250 |
Why?
|
| High-Throughput Nucleotide Sequencing | 21 | 2023 | 3634 | 1.240 |
Why?
|
| Polymorphism, Single Nucleotide | 52 | 2024 | 15908 | 1.240 |
Why?
|
| Gene Frequency | 17 | 2023 | 3601 | 1.230 |
Why?
|
| Transcription Factors | 22 | 2024 | 12116 | 1.180 |
Why?
|
| Cardiomyopathies | 10 | 2023 | 1948 | 1.160 |
Why?
|
| Nerve Tissue Proteins | 12 | 2024 | 4408 | 1.160 |
Why?
|
| Genome, Human | 25 | 2024 | 4421 | 1.150 |
Why?
|
| Cardiomyopathy, Dilated | 9 | 2024 | 831 | 1.150 |
Why?
|
| Radiosurgery | 11 | 2023 | 1339 | 1.140 |
Why?
|
| Young Adult | 116 | 2024 | 59191 | 1.130 |
Why?
|
| Infant, Newborn | 73 | 2024 | 26183 | 1.120 |
Why?
|
| Alleles | 34 | 2024 | 6861 | 1.110 |
Why?
|
| Puberty | 10 | 2024 | 501 | 1.110 |
Why?
|
| Family | 15 | 2024 | 3193 | 1.100 |
Why?
|
| Caveolin 1 | 4 | 2017 | 255 | 1.070 |
Why?
|
| RNA Splicing | 6 | 2023 | 898 | 1.050 |
Why?
|
| Hernia, Diaphragmatic | 8 | 2017 | 244 | 1.050 |
Why?
|
| Brain Diseases | 6 | 2022 | 1546 | 1.050 |
Why?
|
| Survival of Motor Neuron 1 Protein | 5 | 2021 | 64 | 1.040 |
Why?
|
| Muscular Dystrophy, Duchenne | 3 | 2023 | 265 | 1.030 |
Why?
|
| Mitochondrial Proteins | 4 | 2024 | 974 | 1.020 |
Why?
|
| Genome-Wide Association Study | 37 | 2024 | 12661 | 1.010 |
Why?
|
| Muscular Atrophy, Spinal | 5 | 2020 | 258 | 0.990 |
Why?
|
| Parents | 14 | 2023 | 3563 | 0.970 |
Why?
|
| Tracheoesophageal Fistula | 3 | 2023 | 131 | 0.960 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 2 | 2022 | 53 | 0.960 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 10 | 2021 | 115 | 0.960 |
Why?
|
| Genes, Recessive | 7 | 2021 | 623 | 0.950 |
Why?
|
| Ovarian Neoplasms | 19 | 2024 | 4849 | 0.940 |
Why?
|
| Peptide Initiation Factors | 2 | 2021 | 55 | 0.930 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 4 | 2022 | 174 | 0.920 |
Why?
|
| Homozygote | 13 | 2024 | 1776 | 0.920 |
Why?
|
| Body Dysmorphic Disorders | 3 | 2019 | 243 | 0.920 |
Why?
|
| Craniofacial Abnormalities | 3 | 2021 | 319 | 0.910 |
Why?
|
| Leigh Disease | 2 | 2022 | 89 | 0.900 |
Why?
|
| Seizures | 17 | 2024 | 2964 | 0.860 |
Why?
|
| Osteochondrodysplasias | 2 | 2021 | 182 | 0.860 |
Why?
|
| Ventricular Function | 3 | 2023 | 406 | 0.850 |
Why?
|
| Calcium-Binding Proteins | 2 | 2021 | 1066 | 0.850 |
Why?
|
| Disclosure | 11 | 2022 | 747 | 0.850 |
Why?
|
| T-Box Domain Proteins | 4 | 2023 | 469 | 0.850 |
Why?
|
| Prenatal Diagnosis | 7 | 2019 | 1265 | 0.850 |
Why?
|
| ATP-Dependent Proteases | 2 | 2024 | 23 | 0.850 |
Why?
|
| Mixed Function Oxygenases | 4 | 2022 | 265 | 0.830 |
Why?
|
| Biomedical Research | 13 | 2024 | 3426 | 0.820 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 7 | 2021 | 2872 | 0.810 |
Why?
|
| Obesity | 24 | 2023 | 12934 | 0.810 |
Why?
|
| Tooth Abnormalities | 2 | 2021 | 56 | 0.810 |
Why?
|
| Eye Abnormalities | 2 | 2021 | 242 | 0.800 |
Why?
|
| Child Development Disorders, Pervasive | 3 | 2024 | 600 | 0.800 |
Why?
|
| SOXF Transcription Factors | 2 | 2020 | 31 | 0.800 |
Why?
|
| Multifactorial Inheritance | 6 | 2024 | 1381 | 0.790 |
Why?
|
| Syndrome | 16 | 2023 | 3268 | 0.790 |
Why?
|
| Evoked Potentials, Visual | 1 | 2024 | 417 | 0.770 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2024 | 458 | 0.770 |
Why?
|
| Amino Acid Sequence | 23 | 2023 | 13442 | 0.770 |
Why?
|
| Nystagmus, Pathologic | 1 | 2022 | 105 | 0.760 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group F-H | 2 | 2021 | 11 | 0.750 |
Why?
|
| Dystrophin | 1 | 2022 | 281 | 0.750 |
Why?
|
| Esophageal Atresia | 2 | 2023 | 225 | 0.750 |
Why?
|
| Middle Aged | 129 | 2024 | 220603 | 0.740 |
Why?
|
| DNA-Binding Proteins | 9 | 2021 | 9586 | 0.740 |
Why?
|
| Access to Information | 2 | 2014 | 316 | 0.740 |
Why?
|
| Chromosome Aberrations | 7 | 2019 | 1768 | 0.730 |
Why?
|
| Receptors, Leptin | 5 | 2020 | 350 | 0.730 |
Why?
|
| Chromosome Inversion | 1 | 2021 | 120 | 0.730 |
Why?
|
| Haploinsufficiency | 7 | 2024 | 336 | 0.720 |
Why?
|
| Genome | 6 | 2023 | 1737 | 0.710 |
Why?
|
| Long QT Syndrome | 7 | 2019 | 466 | 0.700 |
Why?
|
| Education, Distance | 2 | 2022 | 259 | 0.690 |
Why?
|
| Age of Onset | 15 | 2022 | 3303 | 0.680 |
Why?
|
| Dwarfism | 2 | 2021 | 138 | 0.680 |
Why?
|
| Gene Regulatory Networks | 7 | 2022 | 1745 | 0.680 |
Why?
|
| Genetic Diseases, Inborn | 10 | 2024 | 604 | 0.660 |
Why?
|
| Alcohol Oxidoreductases | 2 | 2019 | 168 | 0.660 |
Why?
|
| Ubiquitin-Protein Ligases | 7 | 2023 | 1894 | 0.650 |
Why?
|
| Hereditary Sensory and Motor Neuropathy | 1 | 2019 | 21 | 0.650 |
Why?
|
| Hip Dislocation, Congenital | 1 | 2021 | 224 | 0.650 |
Why?
|
| Valine-tRNA Ligase | 1 | 2018 | 2 | 0.640 |
Why?
|
| Verbal Behavior | 1 | 2020 | 335 | 0.640 |
Why?
|
| Hearing Loss | 4 | 2023 | 781 | 0.640 |
Why?
|
| Rare Diseases | 5 | 2024 | 622 | 0.630 |
Why?
|
| Lewy Body Disease | 1 | 2021 | 254 | 0.630 |
Why?
|
| Nervous System Diseases | 7 | 2024 | 1662 | 0.630 |
Why?
|
| GATA6 Transcription Factor | 2 | 2020 | 50 | 0.630 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2021 | 618 | 0.630 |
Why?
|
| Hexokinase | 1 | 2019 | 124 | 0.620 |
Why?
|
| Calcium Channels | 1 | 2022 | 620 | 0.610 |
Why?
|
| Frontotemporal Dementia | 1 | 2021 | 245 | 0.610 |
Why?
|
| Gene Duplication | 5 | 2016 | 314 | 0.610 |
Why?
|
| New York | 8 | 2024 | 875 | 0.610 |
Why?
|
| Sequence Deletion | 6 | 2019 | 1490 | 0.600 |
Why?
|
| Lymphokines | 1 | 2021 | 925 | 0.600 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2018 | 47 | 0.590 |
Why?
|
| Truth Disclosure | 4 | 2015 | 432 | 0.580 |
Why?
|
| Medical History Taking | 8 | 2020 | 773 | 0.580 |
Why?
|
| Muscle Spasticity | 2 | 2021 | 156 | 0.580 |
Why?
|
| Research Subjects | 2 | 2016 | 249 | 0.570 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2021 | 829 | 0.570 |
Why?
|
| Visual Fields | 1 | 2024 | 1062 | 0.570 |
Why?
|
| Homeodomain Proteins | 5 | 2015 | 2413 | 0.570 |
Why?
|
| Siblings | 9 | 2020 | 824 | 0.570 |
Why?
|
| Registries | 14 | 2024 | 8209 | 0.560 |
Why?
|
| Growth Disorders | 2 | 2021 | 634 | 0.560 |
Why?
|
| Fetus | 3 | 2022 | 1862 | 0.550 |
Why?
|
| Transketolase | 1 | 2016 | 9 | 0.550 |
Why?
|
| Sex Characteristics | 5 | 2016 | 2637 | 0.540 |
Why?
|
| Gene Deletion | 10 | 2021 | 2659 | 0.540 |
Why?
|
| Menarche | 6 | 2024 | 532 | 0.540 |
Why?
|
| Nuclear Localization Signals | 1 | 2016 | 77 | 0.540 |
Why?
|
| Uncertainty | 5 | 2022 | 752 | 0.540 |
Why?
|
| Glucokinase | 3 | 2014 | 102 | 0.540 |
Why?
|
| Caregivers | 4 | 2023 | 2241 | 0.530 |
Why?
|
| Dental Enamel | 1 | 2016 | 60 | 0.530 |
Why?
|
| Protein Phosphatase 1 | 1 | 2016 | 134 | 0.520 |
Why?
|
| Sexual Maturation | 4 | 2020 | 261 | 0.520 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2021 | 725 | 0.520 |
Why?
|
| Death, Sudden, Cardiac | 3 | 2021 | 1551 | 0.520 |
Why?
|
| Intracranial Arteriovenous Malformations | 4 | 2021 | 366 | 0.520 |
Why?
|
| Internal Medicine | 3 | 2019 | 1051 | 0.510 |
Why?
|
| Membrane Transport Proteins | 7 | 2023 | 1034 | 0.510 |
Why?
|
| Amino Acid Substitution | 10 | 2021 | 1739 | 0.510 |
Why?
|
| Risk Factors | 56 | 2024 | 74128 | 0.510 |
Why?
|
| Bartter Syndrome | 1 | 2015 | 23 | 0.500 |
Why?
|
| Brain | 30 | 2024 | 27100 | 0.500 |
Why?
|
| Mitochondrial Encephalomyopathies | 1 | 2015 | 40 | 0.500 |
Why?
|
| Cardiomyopathy, Hypertrophic | 5 | 2023 | 1310 | 0.500 |
Why?
|
| United States | 50 | 2024 | 72292 | 0.500 |
Why?
|
| Optic Atrophy | 3 | 2024 | 79 | 0.490 |
Why?
|
| Electronic Health Records | 16 | 2024 | 4810 | 0.490 |
Why?
|
| Laboratories | 4 | 2022 | 458 | 0.490 |
Why?
|
| Insurance, Life | 1 | 2014 | 14 | 0.490 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2018 | 682 | 0.490 |
Why?
|
| Family Health | 9 | 2018 | 1253 | 0.480 |
Why?
|
| Phosphoproteins | 3 | 2021 | 2445 | 0.480 |
Why?
|
| Receptor, Melanocortin, Type 4 | 4 | 2020 | 129 | 0.480 |
Why?
|
| Diabetes Mellitus | 4 | 2022 | 5838 | 0.480 |
Why?
|
| Decision Making | 9 | 2023 | 3919 | 0.470 |
Why?
|
| Aged | 78 | 2024 | 169092 | 0.470 |
Why?
|
| Visual Acuity | 1 | 2024 | 2676 | 0.470 |
Why?
|
| Case-Control Studies | 31 | 2024 | 22153 | 0.470 |
Why?
|
| Food Preferences | 3 | 2014 | 398 | 0.470 |
Why?
|
| Chromosomes, Human, X | 1 | 2016 | 321 | 0.470 |
Why?
|
| Chloride Channels | 2 | 2015 | 221 | 0.470 |
Why?
|
| Vascular Resistance | 2 | 2016 | 930 | 0.460 |
Why?
|
| Transaminases | 1 | 2015 | 199 | 0.460 |
Why?
|
| Endocrinology | 1 | 2020 | 442 | 0.460 |
Why?
|
| Germ Cells | 5 | 2022 | 634 | 0.450 |
Why?
|
| Arrhythmias, Cardiac | 5 | 2023 | 2234 | 0.450 |
Why?
|
| Limb Deformities, Congenital | 3 | 2021 | 136 | 0.450 |
Why?
|
| Health Care Surveys | 1 | 2021 | 2422 | 0.440 |
Why?
|
| Base Sequence | 16 | 2023 | 12420 | 0.440 |
Why?
|
| Choice Behavior | 3 | 2016 | 825 | 0.440 |
Why?
|
| Cerebral Palsy | 3 | 2024 | 474 | 0.440 |
Why?
|
| Internet | 5 | 2023 | 3094 | 0.430 |
Why?
|
| Retinitis Pigmentosa | 4 | 2022 | 397 | 0.430 |
Why?
|
| Dystonia | 3 | 2023 | 370 | 0.430 |
Why?
|
| Papilloma, Choroid Plexus | 1 | 2012 | 9 | 0.420 |
Why?
|
| Adaptor Proteins, Signal Transducing | 11 | 2024 | 2896 | 0.420 |
Why?
|
| GATA4 Transcription Factor | 2 | 2013 | 124 | 0.420 |
Why?
|
| Electroencephalography | 5 | 2024 | 6240 | 0.420 |
Why?
|
| Emotions | 4 | 2023 | 2741 | 0.420 |
Why?
|
| Insurance Carriers | 1 | 2014 | 155 | 0.420 |
Why?
|
| Activin Receptors, Type II | 2 | 2023 | 123 | 0.420 |
Why?
|
| Hunger | 1 | 2014 | 205 | 0.410 |
Why?
|
| Physicians | 5 | 2023 | 4583 | 0.410 |
Why?
|
| Cohort Studies | 45 | 2024 | 41464 | 0.410 |
Why?
|
| Databases, Genetic | 8 | 2022 | 1742 | 0.410 |
Why?
|
| Haplotypes | 9 | 2020 | 2713 | 0.410 |
Why?
|
| Mandatory Reporting | 1 | 2013 | 123 | 0.400 |
Why?
|
| Sudden Infant Death | 1 | 2015 | 292 | 0.400 |
Why?
|
| Body Mass Index | 19 | 2024 | 12942 | 0.400 |
Why?
|
| Artificial Intelligence | 2 | 2024 | 2575 | 0.400 |
Why?
|
| Carrier Proteins | 9 | 2024 | 4937 | 0.400 |
Why?
|
| Myotonic Disorders | 1 | 2011 | 7 | 0.400 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2013 | 105 | 0.400 |
Why?
|
| Acrodermatitis | 1 | 2011 | 15 | 0.400 |
Why?
|
| Patient Education as Topic | 3 | 2020 | 2315 | 0.400 |
Why?
|
| Glucosylceramidase | 4 | 2018 | 128 | 0.400 |
Why?
|
| Pediatrics | 5 | 2020 | 3589 | 0.390 |
Why?
|
| Wolman Disease | 1 | 2011 | 3 | 0.390 |
Why?
|
| Exons | 10 | 2023 | 2381 | 0.390 |
Why?
|
| Proteins | 8 | 2023 | 6030 | 0.390 |
Why?
|
| Animals | 69 | 2024 | 168202 | 0.390 |
Why?
|
| Infant, Newborn, Diseases | 3 | 2023 | 589 | 0.390 |
Why?
|
| Sterol Esterase | 1 | 2011 | 40 | 0.390 |
Why?
|
| Breast | 6 | 2023 | 1963 | 0.390 |
Why?
|
| Gene Dosage | 8 | 2017 | 1217 | 0.380 |
Why?
|
| Zebrafish | 11 | 2024 | 3005 | 0.380 |
Why?
|
| Preimplantation Diagnosis | 5 | 2014 | 143 | 0.380 |
Why?
|
| Consanguinity | 4 | 2015 | 456 | 0.380 |
Why?
|
| Erythrocytes | 2 | 2019 | 2410 | 0.380 |
Why?
|
| Pregnancy | 27 | 2024 | 29869 | 0.380 |
Why?
|
| Troponin C | 1 | 2011 | 23 | 0.370 |
Why?
|
| Patient Selection | 5 | 2024 | 4237 | 0.370 |
Why?
|
| Tomography, Optical Coherence | 1 | 2024 | 2917 | 0.370 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2011 | 136 | 0.370 |
Why?
|
| Synaptosomal-Associated Protein 25 | 2 | 2020 | 51 | 0.370 |
Why?
|
| Stress, Psychological | 3 | 2021 | 4488 | 0.370 |
Why?
|
| Personal Autonomy | 1 | 2013 | 304 | 0.370 |
Why?
|
| Genetic Pleiotropy | 3 | 2022 | 181 | 0.360 |
Why?
|
| Deficiency Diseases | 1 | 2011 | 74 | 0.360 |
Why?
|
| DNA | 8 | 2021 | 7196 | 0.360 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2011 | 143 | 0.360 |
Why?
|
| Warfarin | 1 | 2019 | 1477 | 0.360 |
Why?
|
| Pharmacogenetics | 3 | 2019 | 675 | 0.360 |
Why?
|
| Risk Assessment | 25 | 2023 | 23974 | 0.360 |
Why?
|
| Consensus | 1 | 2020 | 3117 | 0.350 |
Why?
|
| Motor Neurons | 6 | 2021 | 869 | 0.350 |
Why?
|
| Critical Illness | 1 | 2023 | 2709 | 0.350 |
Why?
|
| Adrenal Hyperplasia, Congenital | 2 | 2008 | 98 | 0.350 |
Why?
|
| Membrane Proteins | 9 | 2020 | 7847 | 0.350 |
Why?
|
| Aneuploidy | 3 | 2024 | 552 | 0.350 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2020 | 4512 | 0.350 |
Why?
|
| Molecular Sequence Data | 14 | 2016 | 17630 | 0.340 |
Why?
|
| Premature Birth | 1 | 2022 | 1782 | 0.340 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 9 | 2014 | 3776 | 0.340 |
Why?
|
| Movement Disorders | 2 | 2024 | 459 | 0.340 |
Why?
|
| Cation Transport Proteins | 2 | 2013 | 327 | 0.340 |
Why?
|
| Anxiety | 4 | 2023 | 4573 | 0.340 |
Why?
|
| Inheritance Patterns | 3 | 2022 | 341 | 0.340 |
Why?
|
| Diaphragm | 3 | 2022 | 351 | 0.330 |
Why?
|
| Lung Diseases | 5 | 2022 | 1909 | 0.330 |
Why?
|
| Adenosine Triphosphatases | 3 | 2023 | 835 | 0.330 |
Why?
|
| Neurogenesis | 1 | 2015 | 862 | 0.320 |
Why?
|
| Prospective Studies | 43 | 2024 | 54364 | 0.320 |
Why?
|
| Nutrigenomics | 1 | 2008 | 24 | 0.320 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2011 | 259 | 0.320 |
Why?
|
| Body Weight | 6 | 2022 | 4615 | 0.320 |
Why?
|
| Epilepsy, Absence | 1 | 2008 | 49 | 0.320 |
Why?
|
| Pilot Projects | 8 | 2024 | 8619 | 0.310 |
Why?
|
| Neoplasms | 12 | 2023 | 22131 | 0.310 |
Why?
|
| Ghrelin | 2 | 2018 | 251 | 0.310 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2009 | 153 | 0.310 |
Why?
|
| Risk | 14 | 2023 | 9603 | 0.300 |
Why?
|
| Estriol | 1 | 2008 | 53 | 0.300 |
Why?
|
| Cleft Lip | 3 | 2022 | 506 | 0.300 |
Why?
|
| Mendelian Randomization Analysis | 3 | 2019 | 1007 | 0.300 |
Why?
|
| Induced Pluripotent Stem Cells | 6 | 2021 | 1851 | 0.300 |
Why?
|
| Canada | 7 | 2024 | 2120 | 0.300 |
Why?
|
| Quality of Life | 7 | 2024 | 13359 | 0.300 |
Why?
|
| Mental Health | 2 | 2020 | 3253 | 0.300 |
Why?
|
| Energy Intake | 3 | 2019 | 2133 | 0.300 |
Why?
|
| Pathology, Molecular | 1 | 2011 | 329 | 0.300 |
Why?
|
| Bone Diseases, Developmental | 2 | 2020 | 131 | 0.300 |
Why?
|
| Health Knowledge, Attitudes, Practice | 7 | 2023 | 4010 | 0.300 |
Why?
|
| Cleft Palate | 3 | 2022 | 589 | 0.300 |
Why?
|
| Histones | 5 | 2024 | 2577 | 0.300 |
Why?
|
| Dietary Fats | 3 | 2014 | 1995 | 0.300 |
Why?
|
| Brain Neoplasms | 5 | 2023 | 9026 | 0.290 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2008 | 1301 | 0.290 |
Why?
|
| Adiposity | 5 | 2014 | 1879 | 0.290 |
Why?
|
| Mice | 38 | 2024 | 81368 | 0.290 |
Why?
|
| Quantitative Trait Loci | 8 | 2021 | 2112 | 0.290 |
Why?
|
| Neoplastic Syndromes, Hereditary | 2 | 2022 | 246 | 0.290 |
Why?
|
| Polymorphism, Genetic | 5 | 2014 | 4242 | 0.290 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 4 | 2017 | 323 | 0.290 |
Why?
|
| Myocytes, Cardiac | 6 | 2024 | 1667 | 0.280 |
Why?
|
| Retrospective Studies | 37 | 2023 | 80583 | 0.270 |
Why?
|
| Muscular Dystrophies | 1 | 2009 | 390 | 0.270 |
Why?
|
| Microfilament Proteins | 2 | 2019 | 1130 | 0.270 |
Why?
|
| Defibrillators, Implantable | 2 | 2014 | 1483 | 0.270 |
Why?
|
| Jordan | 2 | 2023 | 73 | 0.270 |
Why?
|
| Attitude of Health Personnel | 4 | 2015 | 3882 | 0.270 |
Why?
|
| Data Collection | 7 | 2021 | 3316 | 0.270 |
Why?
|
| Mice, Knockout | 10 | 2024 | 14388 | 0.270 |
Why?
|
| Healthcare Disparities | 1 | 2022 | 3351 | 0.270 |
Why?
|
| RNA | 4 | 2023 | 2713 | 0.270 |
Why?
|
| Glucose Transporter Type 1 | 3 | 2011 | 186 | 0.270 |
Why?
|
| Autopsy | 3 | 2021 | 1008 | 0.270 |
Why?
|
| Specialization | 1 | 2011 | 778 | 0.260 |
Why?
|
| Metabolism, Inborn Errors | 2 | 2019 | 284 | 0.260 |
Why?
|
| HEK293 Cells | 9 | 2021 | 4269 | 0.260 |
Why?
|
| Acromegaly | 3 | 2019 | 310 | 0.260 |
Why?
|
| Mitochondria | 5 | 2024 | 3619 | 0.260 |
Why?
|
| Ion Channels | 2 | 2020 | 1039 | 0.260 |
Why?
|
| p120 GTPase Activating Protein | 2 | 2017 | 36 | 0.260 |
Why?
|
| Port-Wine Stain | 2 | 2017 | 33 | 0.260 |
Why?
|
| KCNQ1 Potassium Channel | 3 | 2016 | 102 | 0.260 |
Why?
|
| Amniotic Fluid | 1 | 2008 | 378 | 0.250 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 4 | 2013 | 1650 | 0.250 |
Why?
|
| Genetic Linkage | 1 | 2011 | 2340 | 0.250 |
Why?
|
| Spastic Paraplegia, Hereditary | 2 | 2018 | 168 | 0.250 |
Why?
|
| Biotechnology | 1 | 2007 | 281 | 0.250 |
Why?
|
| Neurodegenerative Diseases | 3 | 2024 | 1085 | 0.250 |
Why?
|
| Leptin | 5 | 2014 | 1595 | 0.250 |
Why?
|
| Janus Kinase 2 | 1 | 2008 | 560 | 0.250 |
Why?
|
| Cytoskeletal Proteins | 4 | 2023 | 1336 | 0.250 |
Why?
|
| Parkinson Disease | 5 | 2019 | 2878 | 0.250 |
Why?
|
| Longevity | 2 | 2024 | 1064 | 0.250 |
Why?
|
| Fatal Outcome | 6 | 2015 | 1835 | 0.250 |
Why?
|
| Practice Guidelines as Topic | 4 | 2022 | 7390 | 0.240 |
Why?
|
| Prognosis | 20 | 2021 | 29601 | 0.240 |
Why?
|
| GABA Plasma Membrane Transport Proteins | 2 | 2022 | 30 | 0.240 |
Why?
|
| Clinical Trials as Topic | 4 | 2019 | 7995 | 0.240 |
Why?
|
| Cherubism | 1 | 2024 | 16 | 0.240 |
Why?
|
| Feeding Behavior | 2 | 2014 | 3183 | 0.240 |
Why?
|
| Receptors, Estrogen | 4 | 2020 | 2208 | 0.240 |
Why?
|
| Motor Skills | 4 | 2024 | 521 | 0.240 |
Why?
|
| Heart | 4 | 2023 | 4403 | 0.240 |
Why?
|
| Receptor, Melatonin, MT1 | 1 | 2024 | 31 | 0.240 |
Why?
|
| Cross-Sectional Studies | 15 | 2024 | 26065 | 0.240 |
Why?
|
| Founder Effect | 4 | 2018 | 185 | 0.240 |
Why?
|
| Forkhead Transcription Factors | 4 | 2022 | 1614 | 0.240 |
Why?
|
| Transforming Growth Factor beta | 5 | 2015 | 1962 | 0.230 |
Why?
|
| Taste | 4 | 2014 | 189 | 0.230 |
Why?
|
| Color Vision | 1 | 2024 | 23 | 0.230 |
Why?
|
| Osteoporosis | 2 | 2024 | 1604 | 0.230 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2022 | 1754 | 0.230 |
Why?
|
| Ankyrins | 1 | 2024 | 123 | 0.230 |
Why?
|
| Phospholipase C gamma | 1 | 2024 | 131 | 0.230 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2022 | 12143 | 0.230 |
Why?
|
| Genetic Diseases, X-Linked | 2 | 2019 | 386 | 0.230 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2017 | 610 | 0.230 |
Why?
|
| Repressor Proteins | 5 | 2023 | 2985 | 0.230 |
Why?
|
| Health Literacy | 2 | 2020 | 443 | 0.230 |
Why?
|
| DNA Primers | 6 | 2014 | 2817 | 0.230 |
Why?
|
| Vesicular Transport Proteins | 3 | 2024 | 376 | 0.230 |
Why?
|
| Aged, 80 and over | 26 | 2023 | 58919 | 0.230 |
Why?
|
| Congenital Disorders of Glycosylation | 2 | 2022 | 50 | 0.220 |
Why?
|
| Attitude | 2 | 2022 | 772 | 0.220 |
Why?
|
| Neuroma, Acoustic | 2 | 2023 | 458 | 0.220 |
Why?
|
| Social Stigma | 2 | 2024 | 769 | 0.220 |
Why?
|
| Dentition, Permanent | 1 | 2023 | 22 | 0.220 |
Why?
|
| Capillaries | 3 | 2017 | 756 | 0.220 |
Why?
|
| Injections, Spinal | 1 | 2024 | 317 | 0.220 |
Why?
|
| Evidence-Based Medicine | 3 | 2020 | 3680 | 0.220 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2017 | 3606 | 0.220 |
Why?
|
| Down Syndrome | 4 | 2020 | 901 | 0.220 |
Why?
|
| Eating | 7 | 2017 | 1535 | 0.220 |
Why?
|
| Anticoagulants | 1 | 2019 | 4785 | 0.220 |
Why?
|
| Europe | 2 | 2020 | 3415 | 0.220 |
Why?
|
| Pancreatic Neoplasms | 6 | 2022 | 5369 | 0.220 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 5430 | 0.220 |
Why?
|
| Chromosome Mapping | 5 | 2020 | 4611 | 0.210 |
Why?
|
| Periventricular Nodular Heterotopia | 1 | 2023 | 53 | 0.210 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2024 | 100 | 0.210 |
Why?
|
| Facies | 3 | 2018 | 222 | 0.210 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2021 | 1971 | 0.210 |
Why?
|
| Spasms, Infantile | 2 | 2020 | 298 | 0.210 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2023 | 61 | 0.210 |
Why?
|
| Karyotyping | 4 | 2014 | 1171 | 0.210 |
Why?
|
| DNA, Complementary | 3 | 2022 | 1989 | 0.210 |
Why?
|
| Body Height | 2 | 2019 | 1565 | 0.210 |
Why?
|
| Body Patterning | 1 | 2007 | 632 | 0.210 |
Why?
|
| Age Factors | 12 | 2021 | 18381 | 0.210 |
Why?
|
| Growth Hormone-Secreting Pituitary Adenoma | 2 | 2016 | 49 | 0.200 |
Why?
|
| Arteriovenous Malformations | 2 | 2017 | 396 | 0.200 |
Why?
|
| New York City | 4 | 2020 | 731 | 0.200 |
Why?
|
| Scoliosis | 2 | 2021 | 740 | 0.200 |
Why?
|
| Recreation Therapy | 1 | 2021 | 2 | 0.200 |
Why?
|
| Ubiquitination | 3 | 2022 | 1006 | 0.200 |
Why?
|
| Myeloproliferative Disorders | 1 | 2008 | 611 | 0.200 |
Why?
|
| Kaplan-Meier Estimate | 8 | 2021 | 6473 | 0.200 |
Why?
|
| Longitudinal Studies | 10 | 2024 | 14599 | 0.200 |
Why?
|
| Genes, p53 | 2 | 2021 | 712 | 0.200 |
Why?
|
| Androgens | 2 | 2020 | 1285 | 0.200 |
Why?
|
| Mental Retardation, X-Linked | 1 | 2022 | 41 | 0.200 |
Why?
|
| Prevalence | 10 | 2023 | 15702 | 0.200 |
Why?
|
| DNA Methylation | 4 | 2020 | 4392 | 0.200 |
Why?
|
| Physician-Patient Relations | 2 | 2019 | 3239 | 0.200 |
Why?
|
| Sequence Alignment | 3 | 2015 | 2178 | 0.200 |
Why?
|
| Ventricular Function, Left | 2 | 2017 | 3873 | 0.200 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2023 | 846 | 0.200 |
Why?
|
| Language | 4 | 2020 | 1541 | 0.200 |
Why?
|
| Neptune | 1 | 2021 | 2 | 0.200 |
Why?
|
| Polyadenylation | 1 | 2023 | 115 | 0.200 |
Why?
|
| Diabetes Mellitus, Lipoatrophic | 1 | 2021 | 9 | 0.200 |
Why?
|
| Vascular Diseases | 3 | 2022 | 1159 | 0.200 |
Why?
|
| Follow-Up Studies | 20 | 2021 | 39062 | 0.190 |
Why?
|
| Qa-SNARE Proteins | 1 | 2021 | 52 | 0.190 |
Why?
|
| Gene Expression Regulation | 11 | 2022 | 11874 | 0.190 |
Why?
|
| Epistasis, Genetic | 2 | 2018 | 350 | 0.190 |
Why?
|
| Trigeminal Neuralgia | 2 | 2018 | 107 | 0.190 |
Why?
|
| Pituitary Neoplasms | 3 | 2019 | 1323 | 0.190 |
Why?
|
| Population Groups | 5 | 2023 | 207 | 0.190 |
Why?
|
| Transposases | 1 | 2022 | 104 | 0.190 |
Why?
|
| Focus Groups | 3 | 2024 | 1409 | 0.190 |
Why?
|
| beta Catenin | 2 | 2024 | 1039 | 0.190 |
Why?
|
| Adaptor Protein Complex 1 | 1 | 2021 | 22 | 0.190 |
Why?
|
| Nuclear Proteins | 7 | 2024 | 5789 | 0.190 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2020 | 3415 | 0.190 |
Why?
|
| Sin3 Histone Deacetylase and Corepressor Complex | 1 | 2021 | 20 | 0.190 |
Why?
|
| Amino Acid Transport System ASC | 2 | 2024 | 16 | 0.190 |
Why?
|
| Aortic Coarctation | 1 | 2023 | 275 | 0.190 |
Why?
|
| Epilepsy, Generalized | 1 | 2023 | 178 | 0.190 |
Why?
|
| Radiation Injuries | 2 | 2019 | 1189 | 0.190 |
Why?
|
| Membrane Glycoproteins | 2 | 2018 | 3688 | 0.190 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2021 | 67 | 0.190 |
Why?
|
| Epigenesis, Genetic | 5 | 2020 | 3794 | 0.190 |
Why?
|
| Epoxy Compounds | 1 | 2021 | 137 | 0.180 |
Why?
|
| Cell Differentiation | 8 | 2024 | 11512 | 0.180 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2021 | 781 | 0.180 |
Why?
|
| Transcription Factors, TFIII | 1 | 2020 | 10 | 0.180 |
Why?
|
| Ribonucleoprotein, U5 Small Nuclear | 1 | 2020 | 7 | 0.180 |
Why?
|
| Mothers | 3 | 2022 | 2194 | 0.180 |
Why?
|
| Epoxide Hydrolases | 1 | 2021 | 122 | 0.180 |
Why?
|
| Qualitative Research | 4 | 2024 | 3017 | 0.180 |
Why?
|
| Neoplasms, Second Primary | 3 | 2021 | 1051 | 0.180 |
Why?
|
| rab3 GTP-Binding Proteins | 1 | 2020 | 29 | 0.180 |
Why?
|
| Predictive Value of Tests | 11 | 2020 | 15250 | 0.180 |
Why?
|
| Organoids | 2 | 2024 | 744 | 0.180 |
Why?
|
| Vinculin | 1 | 2020 | 59 | 0.180 |
Why?
|
| CpG Islands | 3 | 2020 | 1192 | 0.180 |
Why?
|
| Mosaicism | 3 | 2020 | 474 | 0.180 |
Why?
|
| Amyloid Neuropathies, Familial | 1 | 2023 | 151 | 0.180 |
Why?
|
| Research Report | 2 | 2021 | 367 | 0.180 |
Why?
|
| Defense Mechanisms | 1 | 2021 | 180 | 0.180 |
Why?
|
| Peptide Elongation Factors | 1 | 2020 | 62 | 0.180 |
Why?
|
| RNA, Messenger | 10 | 2022 | 12759 | 0.180 |
Why?
|
| Face | 2 | 2016 | 1026 | 0.180 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2020 | 140 | 0.180 |
Why?
|
| Chromatin | 6 | 2023 | 2955 | 0.180 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2023 | 335 | 0.180 |
Why?
|
| Ectodermal Dysplasia | 1 | 2021 | 106 | 0.180 |
Why?
|
| alpha-MSH | 1 | 2020 | 71 | 0.180 |
Why?
|
| Gastritis | 1 | 2022 | 199 | 0.170 |
Why?
|
| Sodium Channels | 4 | 2013 | 339 | 0.170 |
Why?
|
| Overweight | 1 | 2011 | 2417 | 0.170 |
Why?
|
| Hyperglycemia | 1 | 2009 | 1375 | 0.170 |
Why?
|
| Algorithms | 9 | 2023 | 14024 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2018 | 313 | 0.170 |
Why?
|
| Muscle, Skeletal | 5 | 2015 | 4947 | 0.170 |
Why?
|
| Breast Neoplasms, Male | 1 | 2022 | 212 | 0.170 |
Why?
|
| Blood-Brain Barrier | 2 | 2024 | 1027 | 0.170 |
Why?
|
| Gigantism | 1 | 2019 | 15 | 0.170 |
Why?
|
| Strabismus | 1 | 2024 | 317 | 0.170 |
Why?
|
| Telephone | 1 | 2023 | 626 | 0.170 |
Why?
|
| Cerebellum | 4 | 2023 | 1501 | 0.170 |
Why?
|
| Metabolic Diseases | 2 | 2020 | 680 | 0.170 |
Why?
|
| In Situ Hybridization, Fluorescence | 5 | 2021 | 2509 | 0.170 |
Why?
|
| Reference Standards | 1 | 2023 | 1003 | 0.170 |
Why?
|
| Noonan Syndrome | 1 | 2020 | 120 | 0.170 |
Why?
|
| Social Perception | 2 | 2022 | 431 | 0.170 |
Why?
|
| Muscle Weakness | 1 | 2022 | 412 | 0.170 |
Why?
|
| Action Potentials | 4 | 2015 | 1825 | 0.160 |
Why?
|
| Phosphorylase Kinase | 1 | 2019 | 9 | 0.160 |
Why?
|
| MutS Homolog 2 Protein | 2 | 2018 | 197 | 0.160 |
Why?
|
| Zellweger Syndrome | 1 | 2019 | 8 | 0.160 |
Why?
|
| Atrophy | 3 | 2023 | 1632 | 0.160 |
Why?
|
| Symporters | 1 | 2022 | 363 | 0.160 |
Why?
|
| GTP-Binding Proteins | 1 | 2023 | 949 | 0.160 |
Why?
|
| Endocrine Cells | 1 | 2019 | 9 | 0.160 |
Why?
|
| Transaldolase | 1 | 2019 | 10 | 0.160 |
Why?
|
| Fibroblast Growth Factor 10 | 1 | 2019 | 31 | 0.160 |
Why?
|
| Immune System Diseases | 1 | 2021 | 254 | 0.160 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2020 | 166 | 0.160 |
Why?
|
| Morbidity | 2 | 2021 | 1750 | 0.160 |
Why?
|
| Attitude to Health | 2 | 2020 | 2025 | 0.160 |
Why?
|
| Neuromuscular Diseases | 2 | 2017 | 258 | 0.160 |
Why?
|
| Proportional Hazards Models | 11 | 2023 | 12448 | 0.160 |
Why?
|
| Pulmonary Circulation | 2 | 2022 | 737 | 0.160 |
Why?
|
| Energy Metabolism | 4 | 2021 | 2878 | 0.160 |
Why?
|
| Glycogen Storage Disease | 1 | 2019 | 41 | 0.160 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 2019 | 32 | 0.160 |
Why?
|
| Coloboma | 1 | 2019 | 60 | 0.160 |
Why?
|
| Linkage Disequilibrium | 5 | 2021 | 1994 | 0.160 |
Why?
|
| Genes, Dominant | 2 | 2019 | 851 | 0.160 |
Why?
|
| Deafness | 1 | 2023 | 459 | 0.160 |
Why?
|
| Dystonic Disorders | 1 | 2023 | 350 | 0.160 |
Why?
|
| Transposition of Great Vessels | 1 | 2023 | 580 | 0.160 |
Why?
|
| Morals | 2 | 2020 | 289 | 0.160 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2021 | 412 | 0.160 |
Why?
|
| Information Dissemination | 3 | 2020 | 1126 | 0.160 |
Why?
|
| Anticipation, Psychological | 1 | 2019 | 85 | 0.160 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2019 | 82 | 0.160 |
Why?
|
| Financial Management | 1 | 2020 | 160 | 0.160 |
Why?
|
| Male Urogenital Diseases | 1 | 2018 | 48 | 0.160 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2020 | 416 | 0.160 |
Why?
|
| Ventricular Remodeling | 2 | 2020 | 1265 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2020 | 476 | 0.160 |
Why?
|
| Neurocytoma | 1 | 2018 | 29 | 0.160 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2020 | 286 | 0.160 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2020 | 304 | 0.160 |
Why?
|
| Speech | 2 | 2020 | 555 | 0.160 |
Why?
|
| Adrenal Insufficiency | 1 | 2020 | 194 | 0.160 |
Why?
|
| Disease Outbreaks | 3 | 2014 | 1748 | 0.150 |
Why?
|
| Gene Order | 3 | 2013 | 169 | 0.150 |
Why?
|
| Saliva | 2 | 2014 | 828 | 0.150 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 3 | 2024 | 3708 | 0.150 |
Why?
|
| Female Urogenital Diseases | 1 | 2018 | 57 | 0.150 |
Why?
|
| Myosin Heavy Chains | 2 | 2017 | 404 | 0.150 |
Why?
|
| Smad2 Protein | 1 | 2018 | 145 | 0.150 |
Why?
|
| Peroxisomes | 1 | 2019 | 68 | 0.150 |
Why?
|
| Deaf-Blind Disorders | 1 | 2017 | 4 | 0.150 |
Why?
|
| Insurance, Health | 3 | 2019 | 2495 | 0.150 |
Why?
|
| Heart Ventricles | 3 | 2020 | 3796 | 0.150 |
Why?
|
| Insulin | 6 | 2022 | 6593 | 0.150 |
Why?
|
| Societies, Medical | 2 | 2020 | 3901 | 0.150 |
Why?
|
| Growth Differentiation Factor 1 | 1 | 2017 | 6 | 0.150 |
Why?
|
| Parental Consent | 2 | 2015 | 63 | 0.150 |
Why?
|
| Databases, Nucleic Acid | 1 | 2019 | 205 | 0.150 |
Why?
|
| Chlorobenzoates | 2 | 2017 | 6 | 0.150 |
Why?
|
| Policy | 4 | 2023 | 506 | 0.150 |
Why?
|
| Glomus Tumor | 1 | 2018 | 62 | 0.150 |
Why?
|
| Mental Disorders | 4 | 2021 | 6826 | 0.150 |
Why?
|
| Niemann-Pick Disease, Type C | 1 | 2018 | 49 | 0.150 |
Why?
|
| Executive Function | 2 | 2023 | 1391 | 0.150 |
Why?
|
| Extracellular Matrix | 2 | 2019 | 1718 | 0.150 |
Why?
|
| Oral Health | 1 | 2023 | 492 | 0.150 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2018 | 56 | 0.150 |
Why?
|
| Preconception Care | 1 | 2019 | 141 | 0.150 |
Why?
|
| Chorionic Villi Sampling | 2 | 2008 | 35 | 0.150 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2023 | 395 | 0.150 |
Why?
|
| Adenosine Deaminase | 1 | 2020 | 251 | 0.150 |
Why?
|
| Insurance Coverage | 2 | 2019 | 1937 | 0.150 |
Why?
|
| Peroxiredoxins | 1 | 2018 | 51 | 0.150 |
Why?
|
| Echocardiography | 8 | 2020 | 4987 | 0.150 |
Why?
|
| Diarrhea | 2 | 2017 | 1317 | 0.150 |
Why?
|
| Software | 5 | 2021 | 4432 | 0.150 |
Why?
|
| Herpes Simplex | 1 | 2021 | 465 | 0.150 |
Why?
|
| Expert Testimony | 1 | 2020 | 364 | 0.150 |
Why?
|
| Acetate-CoA Ligase | 1 | 2017 | 9 | 0.150 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2017 | 98 | 0.150 |
Why?
|
| Cinnamates | 2 | 2017 | 59 | 0.150 |
Why?
|
| 4-Aminobutyrate Transaminase | 1 | 2017 | 13 | 0.140 |
Why?
|
| Cataract | 1 | 2023 | 832 | 0.140 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2018 | 88 | 0.140 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2020 | 1932 | 0.140 |
Why?
|
| Psychiatry | 3 | 2014 | 1693 | 0.140 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2017 | 20 | 0.140 |
Why?
|
| Adenoma | 2 | 2019 | 2159 | 0.140 |
Why?
|
| Adaptation, Physiological | 2 | 2014 | 1300 | 0.140 |
Why?
|
| Adaptor Protein Complex 4 | 1 | 2017 | 40 | 0.140 |
Why?
|
| Wnt Proteins | 1 | 2021 | 718 | 0.140 |
Why?
|
| Receptor, EphB4 | 1 | 2017 | 39 | 0.140 |
Why?
|
| Introns | 5 | 2023 | 968 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2019 | 225 | 0.140 |
Why?
|
| Health Plan Implementation | 1 | 2020 | 335 | 0.140 |
Why?
|
| Confidence Intervals | 2 | 2021 | 2925 | 0.140 |
Why?
|
| Fibroblasts | 7 | 2021 | 4140 | 0.140 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2023 | 709 | 0.140 |
Why?
|
| SMN Complex Proteins | 1 | 2017 | 41 | 0.140 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2021 | 1250 | 0.140 |
Why?
|
| Anti-Obesity Agents | 1 | 2020 | 227 | 0.140 |
Why?
|
| Body Composition | 4 | 2018 | 2426 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2017 | 119 | 0.140 |
Why?
|
| Lipodystrophy, Congenital Generalized | 1 | 2016 | 10 | 0.140 |
Why?
|
| Cardiac Myosins | 1 | 2017 | 128 | 0.140 |
Why?
|
| RNA Stability | 1 | 2019 | 320 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 15 | 2024 | 36401 | 0.140 |
Why?
|
| Ependymoma | 1 | 2020 | 320 | 0.140 |
Why?
|
| Disease Models, Animal | 11 | 2024 | 18220 | 0.140 |
Why?
|
| Prader-Willi Syndrome | 1 | 2017 | 78 | 0.140 |
Why?
|
| Computational Biology | 5 | 2021 | 3509 | 0.140 |
Why?
|
| Vision Disorders | 1 | 2024 | 1088 | 0.140 |
Why?
|
| Pandemics | 5 | 2021 | 8652 | 0.140 |
Why?
|
| Receptors, Cell Surface | 3 | 2021 | 2802 | 0.140 |
Why?
|
| Intelligence | 3 | 2021 | 923 | 0.140 |
Why?
|
| Urologic Neoplasms | 1 | 2020 | 314 | 0.140 |
Why?
|
| Propylthiouracil | 2 | 2014 | 68 | 0.140 |
Why?
|
| Jervell-Lange Nielsen Syndrome | 1 | 2016 | 4 | 0.140 |
Why?
|
| Ocular Motility Disorders | 1 | 2018 | 144 | 0.140 |
Why?
|
| Appetite Regulation | 1 | 2017 | 84 | 0.140 |
Why?
|
| DNA, Mitochondrial | 1 | 2022 | 865 | 0.140 |
Why?
|
| RNA, Untranslated | 1 | 2020 | 456 | 0.140 |
Why?
|
| Embryo Loss | 1 | 2016 | 55 | 0.140 |
Why?
|
| Protein Biosynthesis | 2 | 2021 | 2100 | 0.140 |
Why?
|
| Ovariectomy | 1 | 2019 | 613 | 0.140 |
Why?
|
| Knowledge Bases | 2 | 2020 | 97 | 0.130 |
Why?
|
| COUP Transcription Factor I | 1 | 2016 | 12 | 0.130 |
Why?
|
| Estrogen Receptor alpha | 2 | 2018 | 583 | 0.130 |
Why?
|
| Extracorporeal Membrane Oxygenation | 4 | 2022 | 1462 | 0.130 |
Why?
|
| Congresses as Topic | 1 | 2021 | 802 | 0.130 |
Why?
|
| Genetic Services | 1 | 2016 | 13 | 0.130 |
Why?
|
| Data Mining | 2 | 2024 | 551 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 15 | 2 | 2020 | 361 | 0.130 |
Why?
|
| Gait | 3 | 2024 | 811 | 0.130 |
Why?
|
| Synaptic Transmission | 2 | 2020 | 1169 | 0.130 |
Why?
|
| RNA Polymerase II | 1 | 2020 | 537 | 0.130 |
Why?
|
| Heart Septal Defects | 1 | 2017 | 190 | 0.130 |
Why?
|
| Insulin-Secreting Cells | 2 | 2013 | 898 | 0.130 |
Why?
|
| Transcription, Genetic | 5 | 2020 | 7583 | 0.130 |
Why?
|
| Severity of Illness Index | 9 | 2021 | 15829 | 0.130 |
Why?
|
| Eyelids | 1 | 2018 | 278 | 0.130 |
Why?
|
| Research Design | 4 | 2019 | 6174 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2021 | 3730 | 0.130 |
Why?
|
| Loss of Heterozygosity | 2 | 2020 | 662 | 0.130 |
Why?
|
| Reimbursement Mechanisms | 1 | 2021 | 667 | 0.130 |
Why?
|
| Kidney Diseases | 3 | 2018 | 2090 | 0.130 |
Why?
|
| Risk Reduction Behavior | 2 | 2020 | 1110 | 0.130 |
Why?
|
| Breast Diseases | 1 | 2019 | 443 | 0.130 |
Why?
|
| Neurology | 2 | 2014 | 784 | 0.130 |
Why?
|
| Casein Kinase II | 1 | 2016 | 122 | 0.130 |
Why?
|
| Gene Expression Profiling | 8 | 2022 | 9417 | 0.130 |
Why?
|
| Cognition | 6 | 2022 | 6988 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2020 | 322 | 0.130 |
Why?
|
| Mice, Mutant Strains | 5 | 2013 | 1748 | 0.130 |
Why?
|
| Cadherins | 1 | 2020 | 901 | 0.130 |
Why?
|
| Disease Susceptibility | 2 | 2019 | 1788 | 0.130 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2024 | 563 | 0.120 |
Why?
|
| Ethics Committees, Research | 2 | 2014 | 196 | 0.120 |
Why?
|
| Reproducibility of Results | 11 | 2021 | 20077 | 0.120 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 2 | 2013 | 72 | 0.120 |
Why?
|
| Ascomycota | 1 | 2015 | 81 | 0.120 |
Why?
|
| Benzylamines | 1 | 2016 | 246 | 0.120 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2021 | 1113 | 0.120 |
Why?
|
| Alternative Splicing | 2 | 2020 | 1088 | 0.120 |
Why?
|
| Giant Axonal Neuropathy | 1 | 2014 | 1 | 0.120 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2021 | 1169 | 0.120 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2015 | 49 | 0.120 |
Why?
|
| Genes, Mitochondrial | 1 | 2015 | 58 | 0.120 |
Why?
|
| NADP | 1 | 2016 | 227 | 0.120 |
Why?
|
| Texas | 5 | 2015 | 403 | 0.120 |
Why?
|
| Collagen Type XVIII | 1 | 2015 | 52 | 0.120 |
Why?
|
| Esophagus | 1 | 2021 | 1031 | 0.120 |
Why?
|
| Trachea | 1 | 2021 | 1089 | 0.120 |
Why?
|
| Marketing | 1 | 2017 | 220 | 0.120 |
Why?
|
| Incidence | 12 | 2020 | 21339 | 0.120 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2019 | 339 | 0.120 |
Why?
|
| Protein Binding | 7 | 2023 | 9345 | 0.120 |
Why?
|
| Pancreatitis | 1 | 2022 | 1097 | 0.120 |
Why?
|
| Phosphorylation | 4 | 2023 | 8311 | 0.120 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2016 | 151 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 2015 | 418 | 0.120 |
Why?
|
| Needs Assessment | 1 | 2021 | 1139 | 0.120 |
Why?
|
| Uracil | 1 | 2016 | 207 | 0.120 |
Why?
|
| Models, Statistical | 2 | 2020 | 5074 | 0.120 |
Why?
|
| Hormones | 1 | 2019 | 869 | 0.120 |
Why?
|
| Renin-Angiotensin System | 2 | 2011 | 737 | 0.120 |
Why?
|
| Consent Forms | 1 | 2014 | 55 | 0.120 |
Why?
|
| Odds Ratio | 8 | 2021 | 9644 | 0.120 |
Why?
|
| Vitamin B 12 | 1 | 2018 | 524 | 0.120 |
Why?
|
| Mitochondrial Diseases | 1 | 2018 | 343 | 0.120 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2021 | 614 | 0.120 |
Why?
|
| Hypothalamus | 4 | 2017 | 999 | 0.120 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2021 | 1140 | 0.120 |
Why?
|
| Video Recording | 1 | 2020 | 965 | 0.120 |
Why?
|
| Legislation as Topic | 1 | 2014 | 76 | 0.120 |
Why?
|
| Lung | 7 | 2024 | 9999 | 0.120 |
Why?
|
| Heart Failure | 5 | 2023 | 11670 | 0.120 |
Why?
|
| Muscle Proteins | 3 | 2009 | 1152 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 8 | 2024 | 22117 | 0.120 |
Why?
|
| Receptors, Adrenergic | 1 | 2014 | 155 | 0.120 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2018 | 569 | 0.120 |
Why?
|
| Cytomegalovirus Infections | 1 | 2021 | 827 | 0.120 |
Why?
|
| Mitral Valve Stenosis | 1 | 2017 | 341 | 0.120 |
Why?
|
| Glycogen Storage Disease Type I | 1 | 2014 | 53 | 0.120 |
Why?
|
| Scleroderma, Localized | 1 | 2015 | 87 | 0.120 |
Why?
|
| Myocardium | 6 | 2023 | 4725 | 0.120 |
Why?
|
| Endostatins | 1 | 2015 | 168 | 0.120 |
Why?
|
| Cilia | 2 | 2019 | 492 | 0.120 |
Why?
|
| Information Storage and Retrieval | 2 | 2021 | 819 | 0.120 |
Why?
|
| Conserved Sequence | 1 | 2017 | 1162 | 0.120 |
Why?
|
| Medicine | 1 | 2022 | 942 | 0.120 |
Why?
|
| Stem Cells | 2 | 2024 | 3514 | 0.120 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2021 | 9277 | 0.120 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2017 | 283 | 0.110 |
Why?
|
| Histone Acetyltransferases | 1 | 2016 | 335 | 0.110 |
Why?
|
| Cryptorchidism | 1 | 2015 | 151 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 2 | 2020 | 1483 | 0.110 |
Why?
|
| Heart Diseases | 2 | 2020 | 2778 | 0.110 |
Why?
|
| Taste Perception | 1 | 2014 | 37 | 0.110 |
Why?
|
| Wolfram Syndrome | 1 | 2013 | 14 | 0.110 |
Why?
|
| Acanthosis Nigricans | 1 | 2013 | 47 | 0.110 |
Why?
|
| Cell Cycle Proteins | 3 | 2021 | 3447 | 0.110 |
Why?
|
| RNA, Neoplasm | 1 | 2016 | 749 | 0.110 |
Why?
|
| Neuropsychological Tests | 4 | 2021 | 7050 | 0.110 |
Why?
|
| Feasibility Studies | 2 | 2023 | 5239 | 0.110 |
Why?
|
| Ubiquinone | 1 | 2015 | 183 | 0.110 |
Why?
|
| Child Development | 3 | 2016 | 2300 | 0.110 |
Why?
|
| Decision Support Techniques | 1 | 2024 | 1999 | 0.110 |
Why?
|
| Self-Assessment | 1 | 2016 | 399 | 0.110 |
Why?
|
| Pluripotent Stem Cells | 2 | 2013 | 796 | 0.110 |
Why?
|
| Intermediate Filament Proteins | 1 | 2014 | 262 | 0.110 |
Why?
|
| Genetic Loci | 4 | 2017 | 2624 | 0.110 |
Why?
|
| Aortic Aneurysm | 1 | 2018 | 648 | 0.110 |
Why?
|
| ROC Curve | 6 | 2021 | 3575 | 0.110 |
Why?
|
| Glutathione | 1 | 2016 | 582 | 0.110 |
Why?
|
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2014 | 38 | 0.110 |
Why?
|
| Pancreas | 1 | 2020 | 1691 | 0.110 |
Why?
|
| Diagnosis, Differential | 7 | 2017 | 12966 | 0.110 |
Why?
|
| Gaucher Disease | 1 | 2014 | 110 | 0.110 |
Why?
|
| Metabolome | 1 | 2020 | 988 | 0.110 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 933 | 0.110 |
Why?
|
| Natural Language Processing | 1 | 2022 | 1166 | 0.110 |
Why?
|
| Amyotrophic Lateral Sclerosis | 3 | 2017 | 1462 | 0.110 |
Why?
|
| Australia | 3 | 2024 | 1249 | 0.110 |
Why?
|
| Whooping Cough | 1 | 2014 | 86 | 0.110 |
Why?
|
| Auditory Pathways | 1 | 2015 | 237 | 0.110 |
Why?
|
| Myofibromatosis | 1 | 2013 | 27 | 0.110 |
Why?
|
| Costs and Cost Analysis | 1 | 2019 | 1663 | 0.110 |
Why?
|
| Imidazoles | 1 | 2019 | 1175 | 0.110 |
Why?
|
| Gene Expression | 7 | 2022 | 7569 | 0.110 |
Why?
|
| Brugada Syndrome | 1 | 2014 | 91 | 0.110 |
Why?
|
| Cells, Cultured | 8 | 2021 | 18937 | 0.110 |
Why?
|
| Leukemia | 1 | 2021 | 1520 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2012 | 453 | 0.110 |
Why?
|
| Population Surveillance | 2 | 2021 | 2597 | 0.110 |
Why?
|
| Patient Access to Records | 1 | 2014 | 119 | 0.110 |
Why?
|
| Mass Screening | 3 | 2020 | 5425 | 0.110 |
Why?
|
| Societies, Scientific | 1 | 2014 | 222 | 0.110 |
Why?
|
| Actins | 2 | 2023 | 2051 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2015 | 638 | 0.110 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2018 | 745 | 0.100 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2020 | 1017 | 0.100 |
Why?
|
| Hematologic Diseases | 1 | 2016 | 496 | 0.100 |
Why?
|
| Sickness Impact Profile | 1 | 2014 | 299 | 0.100 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2017 | 487 | 0.100 |
Why?
|
| Synapses | 1 | 2022 | 1754 | 0.100 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2022 | 2425 | 0.100 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 2014 | 783 | 0.100 |
Why?
|
| MafB Transcription Factor | 1 | 2012 | 25 | 0.100 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2014 | 292 | 0.100 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2013 | 183 | 0.100 |
Why?
|
| alpha-Synuclein | 1 | 2019 | 752 | 0.100 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2015 | 384 | 0.100 |
Why?
|
| Internationality | 1 | 2018 | 1000 | 0.100 |
Why?
|
| Molecular Imaging | 1 | 2019 | 814 | 0.100 |
Why?
|
| Regression Analysis | 2 | 2020 | 6339 | 0.100 |
Why?
|
| COS Cells | 2 | 2017 | 1130 | 0.100 |
Why?
|
| Biological Products | 1 | 2021 | 912 | 0.100 |
Why?
|
| Early Detection of Cancer | 3 | 2016 | 3196 | 0.100 |
Why?
|
| Cardiovascular Diseases | 4 | 2023 | 15498 | 0.100 |
Why?
|
| Sequence Analysis, RNA | 2 | 2018 | 2013 | 0.100 |
Why?
|
| Alanine Transaminase | 1 | 2015 | 601 | 0.100 |
Why?
|
| Point Mutation | 3 | 2020 | 1595 | 0.100 |
Why?
|
| Disability Evaluation | 3 | 2021 | 1835 | 0.100 |
Why?
|
| Oxo-Acid-Lyases | 2 | 2010 | 22 | 0.100 |
Why?
|
| Zinc Sulfate | 1 | 2011 | 18 | 0.100 |
Why?
|
| Open Reading Frames | 2 | 2020 | 813 | 0.100 |
Why?
|
| Echoencephalography | 1 | 2012 | 134 | 0.100 |
Why?
|
| Left-Right Determination Factors | 1 | 2011 | 10 | 0.100 |
Why?
|
| Craniopharyngioma | 1 | 2014 | 276 | 0.100 |
Why?
|
| Duodenum | 1 | 2015 | 491 | 0.100 |
Why?
|
| Cause of Death | 3 | 2021 | 3683 | 0.100 |
Why?
|
| Meningioma | 2 | 2023 | 1215 | 0.100 |
Why?
|
| Lung Transplantation | 3 | 2016 | 1310 | 0.100 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2015 | 350 | 0.100 |
Why?
|
| Tetralogy of Fallot | 1 | 2017 | 618 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2021 | 2057 | 0.100 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 494 | 0.100 |
Why?
|
| Klebsiella Infections | 1 | 2013 | 144 | 0.100 |
Why?
|
| Proteomics | 3 | 2021 | 3836 | 0.100 |
Why?
|
| Contrast Media | 2 | 2023 | 5305 | 0.100 |
Why?
|
| Drosophila | 3 | 2024 | 1494 | 0.100 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2015 | 530 | 0.100 |
Why?
|
| Professional Competence | 1 | 2015 | 431 | 0.100 |
Why?
|
| Fetal Heart | 1 | 2013 | 281 | 0.100 |
Why?
|
| Hypoglycemia | 1 | 2019 | 883 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2023 | 8998 | 0.100 |
Why?
|
| Primary Prevention | 1 | 2019 | 1185 | 0.100 |
Why?
|
| Signal Transduction | 8 | 2020 | 23415 | 0.090 |
Why?
|
| DNA Repeat Expansion | 1 | 2011 | 72 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2024 | 2292 | 0.090 |
Why?
|
| Myotonic Dystrophy | 1 | 2011 | 78 | 0.090 |
Why?
|
| Prostatic Neoplasms | 3 | 2019 | 11107 | 0.090 |
Why?
|
| Socioeconomic Factors | 3 | 2021 | 7805 | 0.090 |
Why?
|
| Treatment Outcome | 13 | 2021 | 64572 | 0.090 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 4845 | 0.090 |
Why?
|
| Peripheral Nerves | 1 | 2015 | 479 | 0.090 |
Why?
|
| Klebsiella pneumoniae | 1 | 2013 | 249 | 0.090 |
Why?
|
| Leukoencephalopathies | 1 | 2014 | 256 | 0.090 |
Why?
|
| Glucocorticoids | 1 | 2020 | 2160 | 0.090 |
Why?
|
| Receptors, Immunologic | 1 | 2017 | 1409 | 0.090 |
Why?
|
| Nerve Block | 1 | 2018 | 705 | 0.090 |
Why?
|
| Failure to Thrive | 1 | 2011 | 140 | 0.090 |
Why?
|
| Glycogen Storage Disease Type III | 1 | 2010 | 13 | 0.090 |
Why?
|
| Sequence Analysis | 1 | 2011 | 240 | 0.090 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2010 | 97 | 0.090 |
Why?
|
| Auditory Cortex | 1 | 2015 | 363 | 0.090 |
Why?
|
| Health Policy | 2 | 2013 | 2682 | 0.090 |
Why?
|
| X-Ray Microtomography | 1 | 2013 | 455 | 0.090 |
Why?
|
| Health Surveys | 1 | 2021 | 4036 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2012 | 350 | 0.090 |
Why?
|
| Colorectal Neoplasms | 2 | 2021 | 6927 | 0.090 |
Why?
|
| Schizophrenia | 3 | 2019 | 6929 | 0.090 |
Why?
|
| Inservice Training | 1 | 2013 | 375 | 0.090 |
Why?
|
| Leukocytes | 2 | 2011 | 2024 | 0.090 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2010 | 52 | 0.090 |
Why?
|
| Diabetes, Gestational | 1 | 2020 | 1250 | 0.090 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2022 | 2252 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2016 | 410 | 0.090 |
Why?
|
| Lod Score | 1 | 2011 | 600 | 0.090 |
Why?
|
| Cell Movement | 2 | 2019 | 5201 | 0.090 |
Why?
|
| Huntington Disease | 2 | 2007 | 1144 | 0.090 |
Why?
|
| Sodium | 2 | 2023 | 1588 | 0.090 |
Why?
|
| Patient-Centered Care | 1 | 2020 | 1419 | 0.090 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2012 | 557 | 0.090 |
Why?
|
| Referral and Consultation | 4 | 2018 | 3599 | 0.090 |
Why?
|
| Syncope | 1 | 2013 | 428 | 0.090 |
Why?
|
| Neoplasm Staging | 3 | 2020 | 11118 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2020 | 2803 | 0.090 |
Why?
|
| Diet | 3 | 2019 | 8049 | 0.090 |
Why?
|
| Disease Progression | 5 | 2020 | 13495 | 0.090 |
Why?
|
| In Situ Hybridization | 1 | 2014 | 1900 | 0.090 |
Why?
|
| Magnetoencephalography | 3 | 2019 | 636 | 0.080 |
Why?
|
| Serratia Infections | 1 | 2009 | 8 | 0.080 |
Why?
|
| Fetal Diseases | 1 | 2015 | 913 | 0.080 |
Why?
|
| Acetylation | 2 | 2024 | 1055 | 0.080 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2007 | 1834 | 0.080 |
Why?
|
| Taste Disorders | 1 | 2009 | 38 | 0.080 |
Why?
|
| Blood Glucose | 4 | 2018 | 6390 | 0.080 |
Why?
|
| Genetic Markers | 4 | 2018 | 2601 | 0.080 |
Why?
|
| Educational Status | 3 | 2023 | 2509 | 0.080 |
Why?
|
| Chymases | 1 | 2009 | 73 | 0.080 |
Why?
|
| Sympathectomy | 1 | 2009 | 70 | 0.080 |
Why?
|
| Oxygen Inhalation Therapy | 3 | 2020 | 410 | 0.080 |
Why?
|
| Respiration, Artificial | 2 | 2017 | 2630 | 0.080 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2009 | 46 | 0.080 |
Why?
|
| Prosencephalon | 1 | 2011 | 305 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2020 | 3115 | 0.080 |
Why?
|
| Low Back Pain | 1 | 2018 | 982 | 0.080 |
Why?
|
| Serratia marcescens | 1 | 2009 | 46 | 0.080 |
Why?
|
| Syringes | 1 | 2009 | 58 | 0.080 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2009 | 135 | 0.080 |
Why?
|
| Gene Knock-In Techniques | 2 | 2021 | 420 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 2270 | 0.080 |
Why?
|
| Survival Rate | 6 | 2023 | 12719 | 0.080 |
Why?
|
| Virulence | 2 | 2023 | 1299 | 0.080 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2015 | 628 | 0.080 |
Why?
|
| Alaska | 1 | 2008 | 70 | 0.080 |
Why?
|
| Infant Mortality | 1 | 2014 | 751 | 0.080 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 1 | 2008 | 38 | 0.080 |
Why?
|
| Convulsants | 1 | 2008 | 70 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2024 | 9310 | 0.080 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2014 | 1241 | 0.080 |
Why?
|
| Urinary Bladder | 1 | 2015 | 1151 | 0.080 |
Why?
|
| Skinfold Thickness | 1 | 2008 | 163 | 0.080 |
Why?
|
| Celiac Disease | 1 | 2017 | 819 | 0.080 |
Why?
|
| National Human Genome Research Institute (U.S.) | 2 | 2020 | 22 | 0.080 |
Why?
|
| United States Food and Drug Administration | 1 | 2017 | 1661 | 0.080 |
Why?
|
| Communication | 4 | 2024 | 3851 | 0.080 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2012 | 447 | 0.080 |
Why?
|
| Child Behavior Disorders | 1 | 2013 | 804 | 0.080 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2013 | 763 | 0.080 |
Why?
|
| Respiratory Mechanics | 1 | 2012 | 699 | 0.080 |
Why?
|
| Hemodynamics | 2 | 2019 | 4160 | 0.080 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2016 | 1608 | 0.080 |
Why?
|
| Enalapril | 1 | 2010 | 312 | 0.080 |
Why?
|
| Bayes Theorem | 3 | 2022 | 2327 | 0.080 |
Why?
|
| Taiwan | 2 | 2009 | 521 | 0.080 |
Why?
|
| Time Factors | 8 | 2021 | 39908 | 0.080 |
Why?
|
| Social Behavior | 1 | 2015 | 1135 | 0.080 |
Why?
|
| Sex Factors | 5 | 2020 | 10549 | 0.080 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2014 | 951 | 0.080 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 2851 | 0.080 |
Why?
|
| Muscle Strength | 1 | 2012 | 624 | 0.080 |
Why?
|
| Matrix Metalloproteinases | 1 | 2010 | 391 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2024 | 4309 | 0.080 |
Why?
|
| Birth Weight | 2 | 2023 | 2101 | 0.080 |
Why?
|
| Protein Stability | 2 | 2021 | 578 | 0.080 |
Why?
|
| Gestational Age | 3 | 2019 | 3577 | 0.070 |
Why?
|
| Acoustic Stimulation | 2 | 2015 | 1235 | 0.070 |
Why?
|
| Disease | 1 | 2013 | 670 | 0.070 |
Why?
|
| Drug Contamination | 1 | 2009 | 151 | 0.070 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2013 | 594 | 0.070 |
Why?
|
| Sensitivity and Specificity | 5 | 2021 | 14649 | 0.070 |
Why?
|
| Genetics, Population | 1 | 2013 | 935 | 0.070 |
Why?
|
| Mammals | 2 | 2024 | 1131 | 0.070 |
Why?
|
| Exercise | 2 | 2021 | 5886 | 0.070 |
Why?
|
| Funnel Chest | 1 | 2008 | 74 | 0.070 |
Why?
|
| Blood Proteins | 1 | 2013 | 1172 | 0.070 |
Why?
|
| Life Expectancy | 1 | 2014 | 1242 | 0.070 |
Why?
|
| Patient Care | 1 | 2013 | 621 | 0.070 |
Why?
|
| Abortion, Eugenic | 1 | 2007 | 39 | 0.070 |
Why?
|
| Guideline Adherence | 2 | 2016 | 2218 | 0.070 |
Why?
|
| Cardiomyopathy, Hypertrophic, Familial | 1 | 2007 | 63 | 0.070 |
Why?
|
| Central Nervous System | 1 | 2015 | 1333 | 0.070 |
Why?
|
| Reproductive Behavior | 1 | 2007 | 27 | 0.070 |
Why?
|
| Zinc | 1 | 2011 | 687 | 0.070 |
Why?
|
| Genes, Lethal | 1 | 2007 | 223 | 0.070 |
Why?
|
| Aspirin | 1 | 2019 | 3127 | 0.070 |
Why?
|
| Amniocentesis | 1 | 2007 | 115 | 0.070 |
Why?
|
| Alopecia | 1 | 2011 | 412 | 0.070 |
Why?
|
| Colon | 1 | 2015 | 1791 | 0.070 |
Why?
|
| Sodium Chloride | 1 | 2009 | 586 | 0.070 |
Why?
|
| Respiratory Tract Infections | 2 | 2012 | 1009 | 0.070 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2021 | 2423 | 0.070 |
Why?
|
| Autophagy | 1 | 2015 | 1327 | 0.070 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2007 | 141 | 0.070 |
Why?
|
| Serine | 2 | 2024 | 830 | 0.070 |
Why?
|
| Alcohol Drinking | 1 | 2019 | 4028 | 0.070 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2007 | 108 | 0.070 |
Why?
|
| Adaptation, Psychological | 2 | 2015 | 2632 | 0.070 |
Why?
|
| Psychomotor Performance | 1 | 2015 | 1882 | 0.070 |
Why?
|
| Marfan Syndrome | 1 | 2008 | 236 | 0.070 |
Why?
|
| Radiation Dosage | 3 | 2015 | 1956 | 0.070 |
Why?
|
| Surgical Wound Infection | 1 | 2015 | 1529 | 0.070 |
Why?
|
| Bone and Bones | 1 | 2017 | 2565 | 0.070 |
Why?
|
| Statistics as Topic | 4 | 2014 | 2358 | 0.070 |
Why?
|
| Electrocardiography | 3 | 2016 | 6346 | 0.070 |
Why?
|
| Embryo, Nonmammalian | 2 | 2023 | 905 | 0.070 |
Why?
|
| Age Distribution | 3 | 2017 | 2872 | 0.070 |
Why?
|
| Connective Tissue Diseases | 1 | 2009 | 285 | 0.060 |
Why?
|
| Potassium Channels | 1 | 2008 | 537 | 0.060 |
Why?
|
| Body Size | 1 | 2008 | 463 | 0.060 |
Why?
|
| Models, Molecular | 4 | 2021 | 5433 | 0.060 |
Why?
|
| Osteoblasts | 2 | 2024 | 1141 | 0.060 |
Why?
|
| Myocardial Contraction | 2 | 2024 | 1515 | 0.060 |
Why?
|
| Infection Control | 1 | 2013 | 982 | 0.060 |
Why?
|
| Monosomy | 1 | 2005 | 52 | 0.060 |
Why?
|
| alpha-Thalassemia | 1 | 2005 | 51 | 0.060 |
Why?
|
| Thyroid Neoplasms | 1 | 2019 | 2332 | 0.060 |
Why?
|
| Tachycardia, Ventricular | 1 | 2014 | 1261 | 0.060 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2013 | 1084 | 0.060 |
Why?
|
| Honduras | 2 | 2017 | 37 | 0.060 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2009 | 390 | 0.060 |
Why?
|
| Ion Channel Gating | 1 | 2007 | 429 | 0.060 |
Why?
|
| Perception | 1 | 2012 | 1199 | 0.060 |
Why?
|
| Self Report | 1 | 2016 | 3727 | 0.060 |
Why?
|
| Heart Transplantation | 3 | 2020 | 3233 | 0.060 |
Why?
|
| Hydrops Fetalis | 1 | 2005 | 113 | 0.060 |
Why?
|
| Medical Oncology | 1 | 2017 | 2317 | 0.060 |
Why?
|
| Arabs | 1 | 2007 | 187 | 0.060 |
Why?
|
| Carnitine Acyltransferases | 1 | 2004 | 8 | 0.060 |
Why?
|
| Abortion, Habitual | 1 | 2005 | 61 | 0.060 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2007 | 195 | 0.060 |
Why?
|
| Motor Activity | 2 | 2013 | 2714 | 0.060 |
Why?
|
| Waist Circumference | 1 | 2008 | 933 | 0.060 |
Why?
|
| Ventricular Fibrillation | 1 | 2007 | 534 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 5493 | 0.060 |
Why?
|
| Health Education | 2 | 2024 | 1049 | 0.060 |
Why?
|
| Forecasting | 2 | 2019 | 2924 | 0.060 |
Why?
|
| Glycogen Storage Disease Type IV | 1 | 2004 | 7 | 0.060 |
Why?
|
| Eugenics | 1 | 2024 | 17 | 0.060 |
Why?
|
| Drosophila Proteins | 2 | 2024 | 1698 | 0.060 |
Why?
|
| Hearing Disorders | 1 | 2005 | 126 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2005 | 346 | 0.060 |
Why?
|
| Psychotic Disorders | 1 | 2019 | 3220 | 0.060 |
Why?
|
| Holoenzymes | 1 | 2023 | 39 | 0.060 |
Why?
|
| Judaism | 1 | 2024 | 32 | 0.060 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2013 | 1551 | 0.060 |
Why?
|
| Colombia | 2 | 2017 | 282 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 3 | 2009 | 6074 | 0.060 |
Why?
|
| Ketoglutarate Dehydrogenase Complex | 1 | 2023 | 21 | 0.060 |
Why?
|
| Sodium-Bicarbonate Symporters | 1 | 2023 | 30 | 0.060 |
Why?
|
| Primary Health Care | 2 | 2022 | 4677 | 0.060 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 2023 | 103 | 0.060 |
Why?
|
| Mice, Transgenic | 3 | 2021 | 9526 | 0.060 |
Why?
|
| Cross Infection | 1 | 2013 | 1422 | 0.060 |
Why?
|
| Protein Multimerization | 2 | 2020 | 982 | 0.060 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2004 | 123 | 0.060 |
Why?
|
| CADASIL | 1 | 2024 | 82 | 0.060 |
Why?
|
| Schools | 1 | 2012 | 1483 | 0.060 |
Why?
|
| Sodium Bicarbonate | 1 | 2023 | 60 | 0.060 |
Why?
|
| COUP Transcription Factor II | 1 | 2023 | 18 | 0.060 |
Why?
|
| Interleukin-1 | 1 | 2007 | 1248 | 0.060 |
Why?
|
| Ganglia, Spinal | 2 | 2018 | 525 | 0.060 |
Why?
|
| Fertilization in Vitro | 2 | 2008 | 1292 | 0.050 |
Why?
|
| Xenopus | 2 | 2019 | 711 | 0.050 |
Why?
|
| Logistic Models | 4 | 2021 | 13248 | 0.050 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2010 | 1517 | 0.050 |
Why?
|
| Neovascularization, Pathologic | 1 | 2014 | 2644 | 0.050 |
Why?
|
| Bariatric Surgery | 1 | 2013 | 992 | 0.050 |
Why?
|
| Influenza, Human | 2 | 2012 | 1521 | 0.050 |
Why?
|
| Mediator Complex | 1 | 2023 | 106 | 0.050 |
Why?
|
| Medicare | 1 | 2021 | 6774 | 0.050 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2008 | 496 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 6403 | 0.050 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2019 | 3611 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2016 | 7963 | 0.050 |
Why?
|
| Tremor | 1 | 2024 | 190 | 0.050 |
Why?
|
| Heart Arrest | 1 | 2013 | 1513 | 0.050 |
Why?
|
| Collectins | 1 | 2022 | 18 | 0.050 |
Why?
|
| Pulmonary Artery | 3 | 2017 | 1927 | 0.050 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2014 | 1727 | 0.050 |
Why?
|
| Patient Care Team | 2 | 2013 | 2515 | 0.050 |
Why?
|
| Infant, Premature | 1 | 2012 | 2107 | 0.050 |
Why?
|
| Bicarbonates | 1 | 2023 | 292 | 0.050 |
Why?
|
| Adipose Tissue | 3 | 2010 | 3310 | 0.050 |
Why?
|
| Hemizygote | 1 | 2022 | 28 | 0.050 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2024 | 2789 | 0.050 |
Why?
|
| Drosophila melanogaster | 2 | 2023 | 1712 | 0.050 |
Why?
|
| Obesity, Morbid | 1 | 2013 | 1276 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3088 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2014 | 3567 | 0.050 |
Why?
|
| Environment | 1 | 2008 | 1123 | 0.050 |
Why?
|
| Mucolipidoses | 1 | 2003 | 82 | 0.050 |
Why?
|
| Synaptotagmins | 1 | 2022 | 53 | 0.050 |
Why?
|
| Calcium | 4 | 2022 | 5717 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3209 | 0.050 |
Why?
|
| Synostosis | 1 | 2022 | 43 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 1 | 2008 | 934 | 0.050 |
Why?
|
| Bacteremia | 1 | 2009 | 977 | 0.050 |
Why?
|
| Tinnitus | 1 | 2005 | 196 | 0.050 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2013 | 473 | 0.050 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2023 | 254 | 0.050 |
Why?
|
| RNA Splice Sites | 2 | 2018 | 210 | 0.050 |
Why?
|
| Aorta, Thoracic | 1 | 2008 | 1096 | 0.050 |
Why?
|
| Heart Conduction System | 1 | 2007 | 992 | 0.050 |
Why?
|
| Dideoxynucleosides | 1 | 2002 | 135 | 0.050 |
Why?
|
| Inorganic Pyrophosphatase | 1 | 2021 | 3 | 0.050 |
Why?
|
| Weight Loss | 1 | 2013 | 2682 | 0.050 |
Why?
|
| Sex Preselection | 2 | 2014 | 15 | 0.050 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2014 | 2149 | 0.050 |
Why?
|
| Heparin | 1 | 2009 | 1632 | 0.050 |
Why?
|
| Human Growth Hormone | 1 | 2007 | 642 | 0.050 |
Why?
|
| Patient Advocacy | 1 | 2024 | 360 | 0.050 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2024 | 240 | 0.050 |
Why?
|
| Protein Isoforms | 2 | 2020 | 1697 | 0.050 |
Why?
|
| Ulna | 1 | 2022 | 134 | 0.050 |
Why?
|
| Communicable Diseases | 2 | 2007 | 871 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 5334 | 0.050 |
Why?
|
| Apolipoproteins | 1 | 2023 | 326 | 0.050 |
Why?
|
| Prealbumin | 1 | 2023 | 222 | 0.050 |
Why?
|
| North America | 2 | 2021 | 1273 | 0.050 |
Why?
|
| Menopause | 2 | 2020 | 1645 | 0.050 |
Why?
|
| Spinal Cord | 3 | 2017 | 1807 | 0.050 |
Why?
|
| Creatine Kinase | 1 | 2023 | 685 | 0.050 |
Why?
|
| Postmenopause | 2 | 2022 | 2511 | 0.050 |
Why?
|
| Nuclear Family | 1 | 2022 | 311 | 0.050 |
Why?
|
| Digestive System Abnormalities | 1 | 2021 | 49 | 0.050 |
Why?
|
| Parity | 1 | 2024 | 924 | 0.050 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2021 | 85 | 0.050 |
Why?
|
| Collagen Type VI | 1 | 2020 | 24 | 0.050 |
Why?
|
| Academic Medical Centers | 3 | 2020 | 2756 | 0.050 |
Why?
|
| Africa South of the Sahara | 1 | 2023 | 745 | 0.050 |
Why?
|
| Tissue Distribution | 2 | 2021 | 2261 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 3621 | 0.050 |
Why?
|
| Rats | 3 | 2021 | 23716 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2023 | 516 | 0.040 |
Why?
|
| Facial Paralysis | 1 | 2005 | 346 | 0.040 |
Why?
|
| Kidney Glomerulus | 1 | 2003 | 568 | 0.040 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2002 | 506 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2016 | 3801 | 0.040 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2020 | 44 | 0.040 |
Why?
|
| Skin Pigmentation | 1 | 2002 | 277 | 0.040 |
Why?
|
| Transfection | 3 | 2017 | 5765 | 0.040 |
Why?
|
| Depression | 2 | 2019 | 8132 | 0.040 |
Why?
|
| Quadriplegia | 1 | 2022 | 226 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 2023 | 517 | 0.040 |
Why?
|
| Embryo, Mammalian | 2 | 2021 | 1670 | 0.040 |
Why?
|
| Paraparesis, Spastic | 1 | 2019 | 8 | 0.040 |
Why?
|
| Hydrolysis | 1 | 2021 | 661 | 0.040 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2020 | 94 | 0.040 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2021 | 165 | 0.040 |
Why?
|
| Neuroglia | 2 | 2020 | 954 | 0.040 |
Why?
|
| Liver | 2 | 2019 | 7512 | 0.040 |
Why?
|
| Evolution, Molecular | 2 | 2021 | 1880 | 0.040 |
Why?
|
| Catalytic Domain | 1 | 2022 | 704 | 0.040 |
Why?
|
| Neurons | 4 | 2023 | 9436 | 0.040 |
Why?
|
| Puberty, Precocious | 1 | 2021 | 164 | 0.040 |
Why?
|
| Translocation, Genetic | 1 | 2005 | 1392 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2020 | 223 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 2 | 2013 | 1703 | 0.040 |
Why?
|
| Anxiety Disorders | 2 | 2021 | 2724 | 0.040 |
Why?
|
| Radius | 1 | 2022 | 441 | 0.040 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2024 | 709 | 0.040 |
Why?
|
| Transferrin | 1 | 2020 | 283 | 0.040 |
Why?
|
| Anthropometry | 2 | 2016 | 1338 | 0.040 |
Why?
|
| Azithromycin | 1 | 2020 | 199 | 0.040 |
Why?
|
| Sequence Homology | 1 | 2019 | 196 | 0.040 |
Why?
|
| Health Personnel | 3 | 2022 | 3333 | 0.040 |
Why?
|
| Reproductive History | 1 | 2020 | 210 | 0.040 |
Why?
|
| Genes, Neoplasm | 1 | 2021 | 370 | 0.040 |
Why?
|
| International Agencies | 1 | 2020 | 242 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2009 | 3205 | 0.040 |
Why?
|
| Computers | 1 | 2021 | 591 | 0.040 |
Why?
|
| Carbon Monoxide | 1 | 2022 | 547 | 0.040 |
Why?
|
| Structure-Activity Relationship | 2 | 2020 | 3074 | 0.040 |
Why?
|
| Varicose Veins | 1 | 2020 | 156 | 0.040 |
Why?
|
| Genetic Vectors | 2 | 2021 | 3392 | 0.040 |
Why?
|
| Recurrence | 3 | 2018 | 8426 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2023 | 839 | 0.040 |
Why?
|
| Rett Syndrome | 1 | 2020 | 163 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 2023 | 754 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2011 | 3412 | 0.040 |
Why?
|
| Cell Proliferation | 3 | 2024 | 10429 | 0.040 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2019 | 199 | 0.040 |
Why?
|
| Communications Media | 1 | 2018 | 42 | 0.040 |
Why?
|
| Glycogen | 1 | 2019 | 251 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 11069 | 0.040 |
Why?
|
| Insulin Resistance | 2 | 2017 | 3954 | 0.040 |
Why?
|
| Skin | 1 | 2012 | 4472 | 0.040 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2022 | 409 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 2 | 2014 | 871 | 0.040 |
Why?
|
| Gadolinium | 1 | 2023 | 959 | 0.040 |
Why?
|
| Weight Gain | 2 | 2021 | 2349 | 0.040 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2023 | 841 | 0.040 |
Why?
|
| Guidelines as Topic | 2 | 2019 | 1386 | 0.040 |
Why?
|
| New Zealand | 1 | 2018 | 358 | 0.040 |
Why?
|
| Information Systems | 1 | 2020 | 396 | 0.040 |
Why?
|
| Satiation | 1 | 2018 | 82 | 0.040 |
Why?
|
| Reproduction | 1 | 2022 | 646 | 0.040 |
Why?
|
| Dioxygenases | 1 | 2020 | 344 | 0.040 |
Why?
|
| Interview, Psychological | 1 | 2021 | 809 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2020 | 1229 | 0.040 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2017 | 851 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2019 | 214 | 0.040 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2018 | 100 | 0.040 |
Why?
|
| Organogenesis | 1 | 2019 | 214 | 0.040 |
Why?
|
| Meta-Analysis as Topic | 2 | 2017 | 1380 | 0.040 |
Why?
|
| Japan | 1 | 2021 | 1372 | 0.040 |
Why?
|
| Flumazenil | 1 | 2017 | 84 | 0.040 |
Why?
|
| Glycosylation | 1 | 2020 | 1098 | 0.040 |
Why?
|
| Genetic Engineering | 1 | 2023 | 931 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 4569 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2019 | 927 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2002 | 1327 | 0.030 |
Why?
|
| GABA Modulators | 1 | 2017 | 109 | 0.030 |
Why?
|
| Dimerization | 1 | 2018 | 890 | 0.030 |
Why?
|
| Stroke | 1 | 2019 | 9715 | 0.030 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2017 | 114 | 0.030 |
Why?
|
| Exercise Test | 2 | 2015 | 2127 | 0.030 |
Why?
|
| Caveolae | 1 | 2016 | 54 | 0.030 |
Why?
|
| Walking | 1 | 2024 | 1197 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2020 | 1575 | 0.030 |
Why?
|
| Probability | 1 | 2022 | 2475 | 0.030 |
Why?
|
| Disease Management | 2 | 2019 | 2506 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2018 | 535 | 0.030 |
Why?
|
| Double-Blind Method | 3 | 2020 | 12333 | 0.030 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2020 | 702 | 0.030 |
Why?
|
| Neoplasm Metastasis | 2 | 2019 | 4910 | 0.030 |
Why?
|
| Hydroxychloroquine | 1 | 2020 | 426 | 0.030 |
Why?
|
| Cyclophilins | 1 | 2016 | 48 | 0.030 |
Why?
|
| Telomere-Binding Proteins | 1 | 2017 | 119 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2018 | 495 | 0.030 |
Why?
|
| Calibration | 1 | 2019 | 817 | 0.030 |
Why?
|
| tRNA Methyltransferases | 1 | 2016 | 51 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2023 | 1048 | 0.030 |
Why?
|
| Mice, Obese | 2 | 2008 | 418 | 0.030 |
Why?
|
| Fathers | 1 | 2019 | 375 | 0.030 |
Why?
|
| Stroke Volume | 3 | 2017 | 5486 | 0.030 |
Why?
|
| Professional-Patient Relations | 2 | 2014 | 724 | 0.030 |
Why?
|
| Azacitidine | 1 | 2018 | 335 | 0.030 |
Why?
|
| Arkansas | 1 | 2015 | 59 | 0.030 |
Why?
|
| Fibrosis | 1 | 2023 | 2047 | 0.030 |
Why?
|
| Human Rights | 1 | 2019 | 309 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2020 | 790 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2024 | 1355 | 0.030 |
Why?
|
| Informed Consent By Minors | 1 | 2015 | 9 | 0.030 |
Why?
|
| Apoptosis | 2 | 2024 | 9476 | 0.030 |
Why?
|
| Appetite | 1 | 2018 | 247 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2009 | 4438 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2002 | 1348 | 0.030 |
Why?
|
| Aldosterone | 2 | 2011 | 869 | 0.030 |
Why?
|
| Geography | 1 | 2018 | 652 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 360 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2017 | 6807 | 0.030 |
Why?
|
| Demography | 1 | 2020 | 1643 | 0.030 |
Why?
|
| Memory Disorders | 1 | 2023 | 1197 | 0.030 |
Why?
|
| Acute Disease | 2 | 2022 | 7236 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2022 | 1320 | 0.030 |
Why?
|
| Mother-Child Relations | 1 | 2019 | 496 | 0.030 |
Why?
|
| Oxidoreductases | 1 | 2018 | 412 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2013 | 6345 | 0.030 |
Why?
|
| Iran | 1 | 2018 | 737 | 0.030 |
Why?
|
| Transcription Factor TFIIIA | 1 | 2015 | 24 | 0.030 |
Why?
|
| Liver Diseases | 1 | 2024 | 1297 | 0.030 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2020 | 619 | 0.030 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2015 | 80 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2015 | 223 | 0.030 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2018 | 364 | 0.030 |
Why?
|
| Cell Line | 3 | 2018 | 15577 | 0.030 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 16968 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2005 | 1810 | 0.030 |
Why?
|
| Workflow | 1 | 2020 | 849 | 0.030 |
Why?
|
| Survival of Motor Neuron 2 Protein | 1 | 2015 | 49 | 0.030 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2017 | 266 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2023 | 1051 | 0.030 |
Why?
|
| ras Proteins | 1 | 2020 | 1054 | 0.030 |
Why?
|
| Organ Size | 1 | 2020 | 2252 | 0.030 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2024 | 1171 | 0.030 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2014 | 72 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2023 | 1872 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2014 | 52 | 0.030 |
Why?
|
| Auditory Perception | 1 | 2019 | 583 | 0.030 |
Why?
|
| Biological Evolution | 1 | 2020 | 1070 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2019 | 634 | 0.030 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2014 | 69 | 0.030 |
Why?
|
| Genomic Imprinting | 1 | 2016 | 329 | 0.030 |
Why?
|
| Syndactyly | 1 | 2015 | 74 | 0.030 |
Why?
|
| Medical Record Linkage | 1 | 2016 | 286 | 0.030 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2015 | 120 | 0.030 |
Why?
|
| Florida | 1 | 2015 | 429 | 0.030 |
Why?
|
| Premenopause | 1 | 2018 | 1038 | 0.030 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2016 | 304 | 0.030 |
Why?
|
| Taste Buds | 1 | 2014 | 24 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2019 | 12043 | 0.030 |
Why?
|
| Zebrafish Proteins | 1 | 2020 | 1013 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 8542 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 1608 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2017 | 1089 | 0.030 |
Why?
|
| Health Behavior | 2 | 2016 | 2643 | 0.030 |
Why?
|
| Social Behavior Disorders | 1 | 2014 | 96 | 0.030 |
Why?
|
| Intermediate Filaments | 1 | 2014 | 171 | 0.030 |
Why?
|
| Spectrum Analysis | 1 | 2016 | 452 | 0.030 |
Why?
|
| Health | 2 | 2007 | 398 | 0.030 |
Why?
|
| American Heart Association | 1 | 2018 | 1039 | 0.030 |
Why?
|
| Urocortins | 1 | 2013 | 19 | 0.030 |
Why?
|
| Ventricular Pressure | 1 | 2014 | 210 | 0.030 |
Why?
|
| Sweden | 1 | 2017 | 1379 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2017 | 793 | 0.030 |
Why?
|
| Markov Chains | 2 | 2007 | 965 | 0.030 |
Why?
|
| Linear Models | 2 | 2014 | 5866 | 0.030 |
Why?
|
| Mammary Glands, Human | 1 | 2015 | 202 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2014 | 217 | 0.030 |
Why?
|
| Phenylbutyrates | 1 | 2013 | 72 | 0.030 |
Why?
|
| Thinness | 1 | 2017 | 480 | 0.030 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2019 | 786 | 0.030 |
Why?
|
| Genes, Developmental | 1 | 2013 | 38 | 0.030 |
Why?
|
| Antiporters | 1 | 2014 | 276 | 0.030 |
Why?
|
| Sample Size | 1 | 2016 | 838 | 0.030 |
Why?
|
| Glucose | 2 | 2017 | 4345 | 0.030 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2014 | 181 | 0.030 |
Why?
|
| Mastectomy | 1 | 2021 | 1817 | 0.030 |
Why?
|
| Mice, Inbred C3H | 2 | 2006 | 913 | 0.030 |
Why?
|
| Mexiletine | 1 | 2013 | 30 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2017 | 699 | 0.030 |
Why?
|
| Estrogens | 1 | 2020 | 1521 | 0.030 |
Why?
|
| Motivation | 1 | 2023 | 2003 | 0.030 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2014 | 436 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2015 | 10072 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2023 | 1865 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2017 | 1463 | 0.030 |
Why?
|
| Biophysics | 1 | 2014 | 379 | 0.030 |
Why?
|
| Flecainide | 1 | 2013 | 41 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2016 | 1525 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2017 | 2495 | 0.030 |
Why?
|
| beta-Lactam Resistance | 1 | 2013 | 73 | 0.030 |
Why?
|
| Health Status | 2 | 2018 | 4076 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2019 | 3088 | 0.030 |
Why?
|
| Intubation, Intratracheal | 1 | 2020 | 1331 | 0.030 |
Why?
|
| Nucleotides | 1 | 2015 | 453 | 0.030 |
Why?
|
| Diagnostic Imaging | 2 | 2017 | 3527 | 0.030 |
Why?
|
| Pattern Recognition, Automated | 1 | 2018 | 994 | 0.030 |
Why?
|
| Multigene Family | 1 | 2015 | 1076 | 0.030 |
Why?
|
| Neuromuscular Junction | 1 | 2015 | 405 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2018 | 1988 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2015 | 836 | 0.020 |
Why?
|
| Escherichia coli Infections | 2 | 2006 | 518 | 0.020 |
Why?
|
| Endoscopy | 1 | 2022 | 1851 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2021 | 2456 | 0.020 |
Why?
|
| Dietary Sucrose | 1 | 2014 | 243 | 0.020 |
Why?
|
| Protein Folding | 1 | 2016 | 870 | 0.020 |
Why?
|
| Biophysical Phenomena | 1 | 2013 | 319 | 0.020 |
Why?
|
| Guanosine | 1 | 2011 | 46 | 0.020 |
Why?
|
| Cats | 1 | 2013 | 974 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2013 | 5034 | 0.020 |
Why?
|
| Binding Sites | 1 | 2020 | 6051 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2015 | 5965 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2015 | 991 | 0.020 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2013 | 239 | 0.020 |
Why?
|
| Connexins | 1 | 2013 | 352 | 0.020 |
Why?
|
| Lentivirus | 1 | 2014 | 507 | 0.020 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2013 | 361 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2018 | 2703 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2021 | 3431 | 0.020 |
Why?
|
| Receptors, Nicotinic | 1 | 2015 | 495 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 3419 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2023 | 2175 | 0.020 |
Why?
|
| Intelligence Tests | 1 | 2012 | 503 | 0.020 |
Why?
|
| Tubulin | 1 | 2015 | 692 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2018 | 1265 | 0.020 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2014 | 582 | 0.020 |
Why?
|
| Child Welfare | 1 | 2015 | 521 | 0.020 |
Why?
|
| 3-O-Methylglucose | 1 | 2010 | 37 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2013 | 639 | 0.020 |
Why?
|
| Embryonic Stem Cells | 2 | 2008 | 1262 | 0.020 |
Why?
|
| Myelin Sheath | 1 | 2015 | 653 | 0.020 |
Why?
|
| Private Sector | 1 | 2014 | 394 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2017 | 1492 | 0.020 |
Why?
|
| Genes | 1 | 2015 | 1823 | 0.020 |
Why?
|
| beta-Lactamases | 1 | 2013 | 304 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2003 | 3672 | 0.020 |
Why?
|
| Protein Transport | 1 | 2016 | 1966 | 0.020 |
Why?
|
| Cathepsin L | 1 | 2010 | 69 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2015 | 790 | 0.020 |
Why?
|
| Interferon Regulatory Factors | 1 | 2012 | 261 | 0.020 |
Why?
|
| Proteome | 1 | 2021 | 1857 | 0.020 |
Why?
|
| Combined Modality Therapy | 2 | 2015 | 8516 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2023 | 3550 | 0.020 |
Why?
|
| Angiotensins | 1 | 2011 | 142 | 0.020 |
Why?
|
| Biological Transport | 1 | 2015 | 2089 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2015 | 2278 | 0.020 |
Why?
|
| Anisotropy | 1 | 2014 | 1283 | 0.020 |
Why?
|
| Methylation | 1 | 2013 | 1077 | 0.020 |
Why?
|
| Philadelphia | 1 | 2011 | 267 | 0.020 |
Why?
|
| Molecular Sequence Annotation | 1 | 2012 | 520 | 0.020 |
Why?
|
| Genes, p16 | 1 | 2010 | 160 | 0.020 |
Why?
|
| Cognition Disorders | 2 | 2014 | 3979 | 0.020 |
Why?
|
| Knee | 1 | 2011 | 279 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2015 | 1074 | 0.020 |
Why?
|
| Thiourea | 1 | 2009 | 68 | 0.020 |
Why?
|
| Hippocampus | 1 | 2022 | 3762 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2023 | 3196 | 0.020 |
Why?
|
| Neoplasm, Residual | 1 | 2014 | 1008 | 0.020 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2024 | 3204 | 0.020 |
Why?
|
| Endothelium, Vascular | 2 | 2013 | 4433 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2020 | 8165 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 2639 | 0.020 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2011 | 363 | 0.020 |
Why?
|
| Cardiovascular Agents | 1 | 2015 | 840 | 0.020 |
Why?
|
| Response Elements | 1 | 2010 | 309 | 0.020 |
Why?
|
| Sarcomeres | 1 | 2012 | 369 | 0.020 |
Why?
|
| Intestine, Small | 1 | 2015 | 1207 | 0.020 |
Why?
|
| Renin | 1 | 2011 | 640 | 0.020 |
Why?
|
| Electromyography | 1 | 2014 | 1392 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2011 | 677 | 0.020 |
Why?
|
| Medical Informatics | 1 | 2016 | 732 | 0.020 |
Why?
|
| Community-Institutional Relations | 1 | 2010 | 206 | 0.020 |
Why?
|
| Retina | 1 | 2019 | 2655 | 0.020 |
Why?
|
| Vital Capacity | 1 | 2011 | 971 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2019 | 2921 | 0.020 |
Why?
|
| Aorta | 1 | 2016 | 2041 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2013 | 1635 | 0.020 |
Why?
|
| Schizophrenic Psychology | 1 | 2016 | 1646 | 0.020 |
Why?
|
| Confidentiality | 1 | 2013 | 608 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2016 | 1505 | 0.020 |
Why?
|
| Vulnerable Populations | 1 | 2014 | 705 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2013 | 743 | 0.020 |
Why?
|
| Mitral Valve | 1 | 2017 | 1464 | 0.020 |
Why?
|
| Diseases in Twins | 1 | 2010 | 446 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2020 | 5109 | 0.020 |
Why?
|
| Developing Countries | 1 | 2020 | 2868 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2013 | 2669 | 0.020 |
Why?
|
| Semantics | 1 | 2011 | 612 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2018 | 2977 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2018 | 3546 | 0.020 |
Why?
|
| Bardet-Biedl Syndrome | 1 | 2008 | 51 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2010 | 915 | 0.020 |
Why?
|
| Phylogeny | 1 | 2015 | 2805 | 0.020 |
Why?
|
| Bone Density | 1 | 2020 | 3548 | 0.020 |
Why?
|
| Education | 1 | 2010 | 534 | 0.020 |
Why?
|
| Biological Specimen Banks | 1 | 2013 | 778 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2018 | 2674 | 0.020 |
Why?
|
| Cerebral Hemorrhage | 1 | 2018 | 2642 | 0.020 |
Why?
|
| Hospitalization | 2 | 2020 | 10708 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 3705 | 0.020 |
Why?
|
| Staphylococcal Infections | 2 | 2006 | 1406 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2013 | 928 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2013 | 1467 | 0.020 |
Why?
|
| Observer Variation | 1 | 2013 | 2607 | 0.020 |
Why?
|
| Asperger Syndrome | 1 | 2007 | 57 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 2008 | 527 | 0.020 |
Why?
|
| Guilt | 1 | 2007 | 95 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2011 | 1129 | 0.020 |
Why?
|
| Psychometrics | 1 | 2016 | 3062 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2015 | 2135 | 0.020 |
Why?
|
| Prenatal Care | 1 | 2014 | 1140 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2008 | 473 | 0.020 |
Why?
|
| Axons | 1 | 2014 | 1671 | 0.020 |
Why?
|
| Agouti Signaling Protein | 1 | 2006 | 23 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2013 | 1360 | 0.020 |
Why?
|
| Counseling | 1 | 2014 | 1538 | 0.020 |
Why?
|
| Cytogenetic Analysis | 1 | 2007 | 270 | 0.020 |
Why?
|
| Schools, Medical | 1 | 2013 | 878 | 0.020 |
Why?
|
| Length of Stay | 1 | 2020 | 6418 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 3793 | 0.020 |
Why?
|
| Chromogranins | 1 | 2007 | 160 | 0.020 |
Why?
|
| Diet, Fat-Restricted | 1 | 2008 | 329 | 0.020 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2007 | 299 | 0.020 |
Why?
|
| Models, Neurological | 1 | 2014 | 1768 | 0.020 |
Why?
|
| Homeostasis | 1 | 2017 | 3321 | 0.020 |
Why?
|
| Retroviridae | 1 | 2008 | 851 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 2189 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2008 | 593 | 0.020 |
Why?
|
| Oocytes | 1 | 2010 | 1166 | 0.020 |
Why?
|
| Cricetulus | 1 | 2007 | 814 | 0.020 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2016 | 2400 | 0.020 |
Why?
|
| Chromosome Banding | 1 | 2005 | 260 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2017 | 2447 | 0.020 |
Why?
|
| Cell Communication | 1 | 2013 | 1654 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2008 | 901 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2011 | 970 | 0.020 |
Why?
|
| Goals | 1 | 2010 | 708 | 0.020 |
Why?
|
| Biopsy | 2 | 2009 | 6763 | 0.020 |
Why?
|
| CHO Cells | 1 | 2007 | 1387 | 0.010 |
Why?
|
| Maternal Age | 1 | 2008 | 809 | 0.010 |
Why?
|
| 1,4-alpha-Glucan Branching Enzyme | 1 | 2004 | 4 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 2007 | 783 | 0.010 |
Why?
|
| Aminosalicylic Acid | 1 | 2004 | 20 | 0.010 |
Why?
|
| Cytogenetics | 1 | 2005 | 198 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2020 | 5776 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2014 | 6016 | 0.010 |
Why?
|
| Policy Making | 1 | 2008 | 541 | 0.010 |
Why?
|
| Glioblastoma | 1 | 2019 | 3481 | 0.010 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2004 | 105 | 0.010 |
Why?
|
| Testis | 1 | 2007 | 792 | 0.010 |
Why?
|
| Cricetinae | 1 | 2007 | 2424 | 0.010 |
Why?
|
| Hospitals, Pediatric | 1 | 2013 | 1859 | 0.010 |
Why?
|
| Echocardiography, Doppler | 1 | 2007 | 893 | 0.010 |
Why?
|
| Public Policy | 1 | 2008 | 557 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2006 | 1759 | 0.010 |
Why?
|
| Meiosis | 1 | 2005 | 327 | 0.010 |
Why?
|
| Government Regulation | 1 | 2008 | 524 | 0.010 |
Why?
|
| Spain | 1 | 2004 | 487 | 0.010 |
Why?
|
| Postoperative Complications | 2 | 2015 | 15609 | 0.010 |
Why?
|
| Hypothermia, Induced | 1 | 2008 | 754 | 0.010 |
Why?
|
| Streptavidin | 1 | 2002 | 81 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 2008 | 783 | 0.010 |
Why?
|
| Italy | 1 | 2004 | 842 | 0.010 |
Why?
|
| Templates, Genetic | 1 | 2002 | 189 | 0.010 |
Why?
|
| Vacuoles | 1 | 2003 | 228 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2008 | 1329 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 3410 | 0.010 |
Why?
|
| Biotinylation | 1 | 2002 | 184 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2011 | 4117 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 2007 | 981 | 0.010 |
Why?
|
| Research | 1 | 2010 | 1977 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 5780 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 1 | 2010 | 2174 | 0.010 |
Why?
|
| Vaccination | 1 | 2014 | 3370 | 0.010 |
Why?
|
| Fasting | 1 | 2008 | 1603 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 2013 | 2238 | 0.010 |
Why?
|
| Comorbidity | 1 | 2016 | 10507 | 0.010 |
Why?
|
| Hemochromatosis | 1 | 2002 | 174 | 0.010 |
Why?
|
| Pneumococcal Infections | 1 | 2005 | 501 | 0.010 |
Why?
|
| Cell Separation | 1 | 2006 | 1718 | 0.010 |
Why?
|
| Genetic Heterogeneity | 1 | 2004 | 733 | 0.010 |
Why?
|
| Remission Induction | 1 | 2007 | 2391 | 0.010 |
Why?
|
| Adipocytes | 1 | 2008 | 1187 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2010 | 2018 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2004 | 2561 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2009 | 4802 | 0.010 |
Why?
|
| Glycosaminoglycans | 1 | 2003 | 607 | 0.010 |
Why?
|
| Molecular Weight | 1 | 2002 | 2185 | 0.010 |
Why?
|
| Kinetics | 1 | 2007 | 6370 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2007 | 3965 | 0.010 |
Why?
|
| Microspheres | 1 | 2002 | 782 | 0.010 |
Why?
|
| Nephrotic Syndrome | 1 | 2003 | 389 | 0.010 |
Why?
|
| Brain Stem | 1 | 2004 | 858 | 0.010 |
Why?
|
| Lysosomes | 1 | 2004 | 925 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2004 | 2231 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 4172 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2004 | 1808 | 0.010 |
Why?
|
| Transplantation Conditioning | 1 | 2003 | 1590 | 0.010 |
Why?
|
| Heart Rate | 1 | 2007 | 4181 | 0.010 |
Why?
|
| Cytokines | 1 | 2010 | 7373 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2004 | 2851 | 0.010 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2005 | 2152 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 7873 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2004 | 4210 | 0.010 |
Why?
|
| Models, Biological | 1 | 2002 | 9461 | 0.000 |
Why?
|